Document:

Exhibit
10.1

 

AMENDED
AND SECURITIES PURCHASE AGREEMENT

 

This
AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT (the “Agreement”), is made as of November 1, 2017,
by and among Ener-Core, Inc., a Delaware corporation, with headquarters located at 8965 Research Drive, Suite 100, Irvine, California
92618 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (each individually,
an “Initial Buyer” and collectively, the “Initial Buyers”), and amends and restates that
certain Securities Purchase Agreement, dated as of September 19, 2017, by and among the Company and the Buyers (the “Prior
Agreement”).

 

WHEREAS:

 

A.
The Company and each Initial Buyer executed and delivered the Prior Agreement on September 19, 2017 in reliance upon the exemption
from securities registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “1933 Act”),
and Rule 506(b) of Regulation D (“Regulation D”) as promulgated by the United States Securities and Exchange
Commission (the “SEC”) under the 1933 Act.

 

B.
The Company authorized the issuance of senior secured notes of the Company, in substantially the form attached hereto as Exhibit
A (the “Notes”), which Notes are convertible into shares of the Company’s common stock, par value
$0.0001 per share (the “Common Stock”), in accordance with the terms of the Notes.

 

C.
Each Initial Buyer purchased, and the Company sold at the Initial Closing (as defined below), upon the terms and conditions stated
in the Prior Agreement, (i) that aggregate principal amount of Notes set forth opposite such Buyer’s name in column (3)
on the Schedule of Buyers attached thereto (which aggregate principal amount of Notes for all Buyers was $555,555.57) (the “Initial
Notes”) (the shares of Common Stock issuable pursuant to the terms of the Initial Notes, including, without limitation,
upon conversion or otherwise, collectively, the “Initial Conversion Shares”), and (ii) Warrants, in substantially
the form attached hereto as Exhibit B (the “Initial Warrants”), representing the right to acquire that
number of shares of Common Stock set forth opposite such Initial Buyer’s name in column (4) on the Schedule of Buyers (as
exercised, collectively, the “Initial Warrant Shares”).

 

D.
Pursuant to Section 9(e) of the Prior Agreement, any term of the Prior Agreement may be amended only with the written consent
of the Required Holders (as defined therein) and any amendment effected in accordance with Section 9(e) of the Prior Agreement
is binding upon each Initial Buyer and the Company.

 

E.
The Company and the Required Holders wish to amend and restate the Prior Agreement to allow, subject to the terms and conditions
set forth in this Agreement, any Person (as defined below) that, upon approval of the Company and the Required Holders (as defined
below), becomes a Buyer hereunder by duly executing and delivering to the Company a Joinder Agreement (each, a “Joinder
Agreement”) in the form attached hereto as Exhibit C (individually, a “Subsequent Buyer” and
collectively, the “Subsequent Buyers” and together with the Initial Buyers, individually, a “Buyer”
and collectively, the “Buyers”), at the Subsequent Closing (as defined below) to purchase, and require the
Company to sell (i) up to $444,445 aggregate principal amount of Notes (the “Subsequent Notes”, and together
with the Initial Notes, the “Notes”) (the shares of Common Stock issuable pursuant to the terms of the Subsequent
Notes, including, without limitation, upon conversion or otherwise, collectively, the “Subsequent Conversion Shares”,
and together with the Initial Conversion Shares, the “Conversion Shares”) and (ii) Warrants, in substantially
the form attached hereto as Exhibit B (the “Subsequent Warrants”, and together with the Initial Warrants, the
“Warrants”), representing the right to acquire four hundred (400) shares of Common Stock for each $1,000 of
principal amount of Subsequent Notes purchased by such Subsequent Buyer on the Subsequent Closing Date (without regard to any
limitation on conversion set forth in the Subsequent Notes) (as exercised, collectively, the “Subsequent Warrant Shares”,
and together with the Initial Warrants, the “Warrant Shares”).

 

     

     

    

 

F.
The Notes will rank pari passu to all of the Company’s outstanding senior debt as of the date of this Agreement,
and senior to all other outstanding and future indebtedness of the Company, and its Subsidiaries (as defined below), will be guaranteed
by all direct and indirect Subsidiaries (as defined in Section 3(a)) of the Company, currently formed or formed in the future,
as evidenced by that certain First Amendment to Guaranty (the “Guaranty Amendment”), dated as of September
19, 2017, in the form attached as Exhibit C to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC
on September 20, 2017, which amends that certain Guaranty dated November 23, 2016, (as amended or modified from time to time in
accordance with its terms, the “Guaranty Agreement”), and will be secured by a first priority perfected security
interest (subject to Permitted Liens under and as defined in the Notes) in all of the current and future assets of the Company
and all direct and indirect Subsidiaries of the Company, except for the “Excluded Assets” (as such term is defined
in the Security Agreement), currently formed or formed in the future, as evidenced by that certain Third Amendment to the Pledge
and Security Agreement, dated as of September 19, 2017, in the form attached as Exhibit 10.4 to the Company’s Current Report
on Form 8-K filed with the SEC on September 20, 2017 (as amended or modified from time to time in accordance with its terms, the
“Security Amendment Agreement”), which further amends that certain Pledge and Security Agreement, dated as
of April 23, 2015 by and among the Company and the Collateral Agent attached as Exhibit 10.2 to the Company’s Current Report
on Form 8-K filed with the SEC on April 23, 2015 (as amended prior to the date hereof and by the Third Amendment to the Pledge
and Security Agreement dated as of the date hereof, and as further amended or modified from time to time in accordance with its
terms, the “Security Agreement” and together with the Guaranty Agreement and any ancillary documents related
thereto, collectively, the “Security Documents”).

 

G.
The Notes, Conversion Shares, Warrants and Warrant Shares collectively are referred to herein as the “Securities”.

 

NOW,
THEREFORE, the Company and each Buyer hereby agree as follows:

 

1.
PURCHASE AND SALE OF NOTES AND WARRANTS.

 

(a)
Purchase of Notes and Warrants.

 

(i)
Initial Closing. Upon the satisfaction (or waiver) of the conditions set forth in Sections 6(a) and 7(a) below, the Company
issued and sold to each Initial Buyer, and each Initial Buyer severally, but not jointly, agreed to purchase from the Company
on the Initial Closing Date (as defined below), (x) a principal amount of Initial Notes as is set forth opposite such Initial
Buyer’s name in column (3) on the Schedule of Buyers and (y) Initial Warrants to acquire up to that number of Initial Warrant
Shares as is set forth opposite such Initial Buyer’s name in column (4) on the Schedule of Buyers (the “Initial
Closing”).

 

(ii)
Subsequent Closing. Subject to the satisfaction (or waiver) of the conditions set forth in Sections 1(c), 6(b) and 7(b)
below, the Company shall issue and sell to each Subsequent Buyer, and each Subsequent Buyer severally, but not jointly, agrees
to purchase from the Company on the Subsequent Closing Date (as defined below), (x) a principal amount of Subsequent Notes as
set forth on the signature page of such Subsequent Buyer attached to such Subsequent Buyer’s Joinder Agreement or in the
Subsequent Closing Notice (as defined below), as applicable and (y) Subsequent Warrants to acquire four hundred (400) shares of
Common Stock for each $1,000 of principal amount of Subsequent Notes purchased by such Subsequent Buyer on the Subsequent Closing
Date (without regard to any limitation on conversion set forth in the Subsequent Notes) (the “Subsequent Closing”
and together with the Initial Closing, each a “Closing”).

 

    	 	- 2 -	 

     

    

 

(b)
Initial Closing Date. The date and time of the Initial Closing (the “Initial Closing Date”) was 10:00
a.m., New York City time, on September 19, 2017, upon notification of satisfaction (or waiver) of the conditions to the Initial
Closing set forth in Sections 6(a) and 7(a) below, at the offices of the Company.

 

(c)
Subsequent Closing Date.

 

(i)
The date and time of the Subsequent Closing (the “Subsequent Closing Date,” and together with the Initial Closing
Date, each a “Closing Date” and collectively, the “Closing Dates”) shall be 10:00 a.m.,
New York City time, on the date hereof, subject to satisfaction (or waiver) of the conditions to the Subsequent Closing set forth
in Sections 6(b) and 7(b) and the conditions contained in this Section 1(c), at the offices of the Company. Any Person approved
by the Company and the Required Holders may become a Subsequent Buyer and may purchase Subsequent Notes and Subsequent Warrants
by duly executing and delivering a Joinder Agreement to the Company. Any Initial Buyer may also purchase, at such Initial Buyer’s
option, Subsequent Notes and Subsequent Warrants by delivering written notice to the Company (each, a “Subsequent Closing
Notice”). Notwithstanding anything herein, in a Joinder Agreement or in a Subsequent Closing Notice to the contrary,
the number of Subsequent Notes to be purchased by the Subsequent Buyers at the Subsequent Closing shall not exceed $444,445 aggregate
principal amount of Subsequent Notes.

 

(ii)
The Initial Buyers hereby consent to the transactions contemplated by this Section 1(c).

 

(d)
Purchase Price. The aggregate purchase price for the Initial Notes and Initial Warrants purchased by each Initial Buyer
at the Initial Closing (the “Initial Purchase Price”) was the amount set forth opposite each Initial Buyer’s
name in column (5) of the Schedule of Buyers. The aggregate purchase price for the Subsequent Notes and the Subsequent Warrants
to be purchased by each Subsequent Buyer at the Subsequent Closing (the “Subsequent Purchase Price” and together
with the Initial Purchase Price, the “Purchase Price”) shall be the amount set forth on the signature page
of such Subsequent Buyer attached to such Subsequent Buyer’s Joinder Agreement or in the Subsequent Closing Notice (as defined
below), as applicable. Each Buyer shall pay $900 for each $1,000 of principal amount of Notes and related Warrants to be purchased
by such Buyer at the applicable Closing. The Buyers and the Company agree that the Notes and the Warrants constitute an “investment
unit” for purposes of Section 1273(c)(2) of the Internal Revenue Code of 1986, as amended (the “Code”).
The Buyers and the Company mutually agree that the allocation of the issue price of such investment unit between the Notes and
the Warrants in accordance with Section 1273(c)(2) of the Code and Treasury Regulation Section 1.1273-2(h) shall be $145.91 per
$1,000 of Purchase Price to be allocated to the Warrants and the balance of each $1,000 of Purchase Price to be allocated to the
Notes, and neither the Buyers nor the Company shall take any position inconsistent with such allocation in any tax return or in
any judicial or administrative proceeding in respect of taxes.

 

    	 	- 3 -	 

     

    

 

(e)
Form of Payment.

 

(i)
Initial Closing. On the Initial Closing Date, (i) each Initial Buyer paid its Initial Purchase Price to the Company for
the Initial Notes and Initial Warrants issued and sold to such Initial Buyer at the Initial Closing (less, in the case of Empery
Asset Master Ltd. (“Empery”) and affiliated funds of Empery, the amounts withheld pursuant to Section 4(h)),
by wire transfer of immediately available funds in accordance with the Company’s written wire instructions and (ii) the
Company delivered to each Initial Buyer the Initial Notes (allocated in the principal amounts requested by such Initial Buyer)
and Initial Warrants which such Initial Buyer purchased hereunder, in each case duly executed on behalf of the Company and registered
in the name of such Initial Buyer or its designee.

 

(ii)
Subsequent Closing. On the Subsequent Closing Date, (i) each Subsequent Buyer shall pay its Subsequent Purchase Price to
the Company for the Subsequent Notes and the Subsequent Warrants to be issued and sold to such Subsequent Buyer at the Subsequent
Closing by wire transfer of immediately available funds in accordance with the Company’s written wire instructions and (ii)
the Company shall deliver to each Subsequent Buyer the Subsequent Notes (allocated in the principal amounts as such Subsequent
Buyer shall request) which such Subsequent Buyer is then purchasing hereunder along with the Subsequent Warrants (allocated in
the amounts as such Subsequent Buyer shall request) which such Subsequent Buyer is purchasing hereunder, in each case duly executed
on behalf of the Company and registered in the name of such Subsequent Buyer or its designee.

 

2.
BUYER’S REPRESENTATIONS AND WARRANTIES. Each Buyer, severally and not jointly, represents and warrants with respect
to only itself that:

 

(a)
No Public Sale or Distribution. Such Buyer (i) is acquiring the Notes and Warrants, (ii) upon issuance of the Conversion
Shares pursuant to the terms of the Notes will acquire the Conversion Shares issuable pursuant to the terms of the Notes and (iii)
upon exercise of the Warrants will acquire the Warrant Shares pursuant to the terms of the Warrants, for its own account and not
with a view towards, or for resale in connection with, the public sale or distribution thereof, except pursuant to sales registered
or exempted under the 1933 Act; provided, however, that by making the representations herein, such Buyer does not
agree to hold any of the Securities for any minimum or other specific term and reserves the right to dispose of the Securities
at any time in accordance with or pursuant to a registration statement or an exemption under the 1933 Act. Such Buyer is acquiring
the Securities hereunder in the ordinary course of its business. Such Buyer does not presently have any agreement or understanding,
directly or indirectly, with any Person (as defined below) to distribute any of the Securities. For purposes of this Agreement,
“Person” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a
trust, an unincorporated organization and a government or any department or agency thereof.

 

(b)
Accredited Investor Status. Such Buyer is an “accredited investor” as that term is defined in Rule 501(a) of
Regulation D. Such Buyer has executed and delivered to the Company a questionnaire (the “Investor Questionnaire”),
substantially in the form attached hereto as Exhibit D, which such Buyer represents and warrants is true, correct and complete.

 

(c)
Reliance on Exemptions. Such Buyer understands that the Securities are being offered and sold to it in reliance on specific
exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying
in part upon the truth and accuracy of, and such Buyer’s compliance with, the representations, warranties, agreements, acknowledgments
and understandings of such Buyer set forth herein in order to determine the availability of such exemptions and the eligibility
of such Buyer to acquire the Securities.

 

    	 	- 4 -	 

     

    

 

(d)
Information. Such Buyer and its advisors, if any, have been furnished with all materials relating to the business, finances
and operations of the Company and materials relating to the offer and sale of the Securities that have been requested by such
Buyer. Such Buyer and its advisors, if any, have been afforded the opportunity to ask questions of the Company. Neither such inquiries
nor any other due diligence investigations conducted by such Buyer or its advisors, if any, or its representatives shall modify,
amend or affect such Buyer’s right to rely on the Company’s representations and warranties contained herein. Such
Buyer understands that its investment in the Securities involves a high degree of risk and is able to afford a complete loss of
such investment. Such Buyer has sought such accounting, legal and tax advice as it has considered necessary to make an informed
investment decision with respect to its acquisition of the Securities. Such Buyer confirms and agrees that (i) it has independently
evaluated the investment risks and the merits of its decision to purchase the Securities, (ii) it has not relied on the advice
of, or any representations by, any other Person, other than the Company and its officers and directors, in making such decision,
and (iii) no Person, other than the Company and its officers and directors, has any responsibility with respect to the completeness
or accuracy of any information or materials furnished to such Buyer in connection with the transactions contemplated hereby.

 

(e)
No Governmental Review. Such Buyer understands that no United States federal or state agency or any other government or
governmental agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of
the investment in the Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.

 

(f)
Transfer or Resale. Such Buyer understands that: (i) the Securities have not been and are not being registered under the
1933 Act or any state securities laws, and may not be offered for sale, sold, assigned or transferred unless (A) subsequently
registered thereunder, (B) such Buyer shall have delivered to the Company an opinion of counsel, in form and substance reasonably
acceptable to the Company, to the effect that such Securities to be sold, assigned or transferred may be sold, assigned or transferred
pursuant to an exemption from such registration, or (C) such Buyer provides the Company with reasonable assurance that such Securities
can be sold, assigned or transferred pursuant to Rule 144 promulgated under the 1933 Act (“Rule 144”) or Rule
144A promulgated under the 1933 Act, as amended (or successor rules thereto) (collectively, “Resale Exemptions”);
(ii) any sale of the Securities made in reliance on the Resale Exemptions may be made only in accordance with the terms of Rule
144 or Rule 144A, as applicable, and further, if a Resale Exemption is not applicable, any resale of the Securities under circumstances
in which the seller (or the Person) through whom the sale is made) may be deemed to be an underwriter (as that term is defined
in the 1933 Act) may require compliance with some other exemption under the 1933 Act or the rules and regulations of the SEC thereunder;
and (iii) neither the Company nor any other Person is under any obligation to register the Securities under the 1933 Act or any
state securities laws or to comply with the terms and conditions of any exemption thereunder. Notwithstanding the foregoing, the
Securities may be pledged in connection with a bona fide margin account or other loan or financing arrangement secured by the
Securities and such pledge of Securities shall not be deemed to be a transfer, sale or assignment of the Securities hereunder,
and no Buyer effecting a pledge of Securities shall be required to provide the Company with any notice thereof or otherwise make
any delivery to the Company pursuant to this Agreement or any other Transaction Document (as defined in Section 3(b)), including,
without limitation, this Section 2(f).

 

    	 	- 5 -	 

     

    

 

(g)
Legends. Such Buyer understands that the certificates or other instruments representing the Notes and Warrants, and any
certificates representing the Conversion Shares and Warrant Shares, except as set forth below, shall bear any legend as required
by the “blue sky” laws of any state and a restrictive legend in substantially the following form (and a stop-transfer
order may be placed against transfer of such stock certificates or other instruments):

 

[NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES [MAY BE
CONVERTIBLE][ARE EXERCISABLE] HAVE BEEN][THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN] REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD,
TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL, IN FORM AND SUBSTANCE REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION
IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING,
THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY
THE SECURITIES.

 

The
legend set forth above shall be removed and the Company shall issue a certificate or other instrument without such legend to the
holder of the Securities upon which it is stamped or issue to such holder by electronic delivery at the applicable balance account
at The Depository Trust Company (“DTC”), if, unless otherwise required by state securities laws, (i) such Securities
are registered for resale under the 1933 Act, (ii) in connection with a sale, assignment or other transfer, such holder provides
the Company with an opinion of counsel, in form and substance reasonably acceptable to the Company, to the effect that such sale,
assignment or transfer of the Securities may be made without registration under the applicable requirements of the 1933 Act, or
(iii) the Securities can be sold, assigned or transferred pursuant to Rule 144 or Rule 144A. The Company shall be responsible
for the fees of its transfer agent and all DTC fees associated with such issuance.

 

(h)
Validity; Enforcement. This Agreement has been duly and validly authorized, executed and delivered on behalf of such Buyer
and shall constitute the legal, valid and binding obligations of such Buyer enforceable against such Buyer in accordance with
their respective terms, except as such enforceability may be limited by general principles of equity or to applicable bankruptcy,
insolvency, reorganization, moratorium, liquidation and other similar laws relating to, or affecting generally, the enforcement
of applicable creditors’ rights and remedies.

 

(i)
No Conflicts. The execution, delivery and performance by such Buyer of this Agreement and the consummation by such Buyer
of the transactions contemplated hereby and thereby will not (i) result in a violation of the organizational documents of such
Buyer or (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default)
under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument
to which such Buyer is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including
federal and state securities laws) applicable to such Buyer, except in the case of clauses (ii) and (iii) above, for such conflicts,
defaults, rights or violations which would not, individually or in the aggregate, reasonably be expected to have a material adverse
effect on the ability of such Buyer to perform its obligations hereunder.

 

    	 	- 6 -	 

     

    

 

3.
REPRESENTATIONS AND WARRANTIES OF THE COMPANY.

 

The
Company represents and warrants to each of the Buyers, as of the date hereof and as of each applicable Closing Date (unless otherwise
provided herein), that:

 

(a)
Organization and Qualification. Each of the Company and its “Subsidiaries” (which for purposes of this
Agreement means any entity in which the Company, directly or indirectly, owns any of the capital stock or holds an equity or similar
interest) are entities duly organized and validly existing in good standing under the laws of the jurisdiction in which they are
formed, and have the requisite power and authorization to own their properties and to carry on their business as now being conducted.
Each of the Company and its Subsidiaries is duly qualified as a foreign entity to do business and is in good standing in every
jurisdiction in which its ownership of property or the nature of the business conducted by it makes such qualification necessary,
except to the extent that the failure to be so qualified or be in good standing would not reasonably be expected to have a Material
Adverse Effect. As used in this Agreement, “Material Adverse Effect” means any material adverse effect on the
business, properties, assets, operations, results of operations, condition (financial or otherwise) or prospects of the Company
and its Subsidiaries, taken as a whole, or on the transactions contemplated hereby or on the other Transaction Documents or by
the agreements and instruments to be entered into in connection herewith or therewith, or on the authority or ability of the Company
to perform its obligations under the Transaction Documents. The Company has no Subsidiaries except as set forth on Schedule
3(a).

 

(b)
Authorization; Enforcement; Validity. The Company has the requisite power and authority to enter into and perform its obligations
under this Agreement, the Notes, the Warrants, the Irrevocable Transfer Agent Instructions (as defined in Section 5(b)), the Security
Documents, any Joinder Agreements and each of the other agreements entered into by the parties hereto in connection with the transactions
contemplated by this Agreement (collectively, the “Transaction Documents”) and to issue the Securities in accordance
with the terms hereof and thereof. The execution and delivery of the Transaction Documents by the Company and the consummation
by the Company of the transactions contemplated hereby and thereby, including, without limitation, the issuance of the Notes,
the issuance of the Warrants, and the reservation for issuance and the issuance of the Conversion Shares and Warrant Shares have
been duly authorized by the Company’s Board of Directors, and (other than the filing with the SEC of a Form D and any other
filings as may be required by state securities agencies) no further filing, consent, or authorization is required by the Company,
its Board of Directors or its stockholders. This Agreement and the other Transaction Documents have been duly executed and delivered
by the Company, and constitute the legal, valid and binding obligations of the Company, enforceable against the Company in accordance
with their respective terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy,
insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement of applicable
creditors’ rights and remedies. Each of the Subsidiaries party to any of the Transaction Documents has the requisite power
and authority to enter into and perform its obligations under such Transaction Documents., as applicable The execution and delivery
by the Subsidiaries party to any of the Transaction Documents of such Transaction Documents and the consummation by such Subsidiaries
of the transactions contemplated thereby have been duly authorized by such Subsidiaries’ respective boards of directors
(or other applicable governing body) and (other than filings as may be required by state securities agencies) no further filing,
consent, or authorization is required by such Subsidiaries, their respective boards of directors (or other applicable governing
body) or stockholders (or other applicable owners of equity of such Subsidiaries). The Transaction Documents to which any of the
Subsidiaries are parties have been duly executed and delivered by such Subsidiaries, and constitute the legal, valid and binding
obligations of such Subsidiaries, enforceable against them in accordance with their respective terms, except as such enforceability
may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or
similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies.

 

    	 	- 7 -	 

     

    

 

(c)
Issuance of Securities. The issuance of the Notes and the Warrants is duly authorized and, upon issuance, shall be validly
issued and free from all taxes, liens and charges with respect to the issue thereof. As of the applicable Closing, a number of
shares of Common Stock shall have been duly authorized and reserved for issuance which equals or exceeds (the “Required
Reserved Amount) the sum of (i) the maximum number of Conversion Shares issued and issuable pursuant to the Notes to be issued
in such Closing based on the initial Conversion Price (as defined in the Notes) of $2.50 (as adjusted for any stock dividend,
stock split, stock combination, reclassification or similar transaction occurring after the date hereof and without taking into
account any limitations on the issuance thereof pursuant to the terms of the Notes) (the “Initial Conversion Price”)
plus (ii) the maximum number of Warrant Shares issued and issuable pursuant to the Warrants to be issued in such Closing, each
as of the Trading Day (as defined in the Warrants) immediately preceding the applicable date of determination (without taking
into account any limitations on the exercise of the Warrants set forth in the Warrants). As of the date hereof, there are 195,918,607
shares of Common Stock authorized and unissued, of which 10,730,226 are reserved for issuance upon full exercise of all outstanding
options and warrants and upon conversion of all convertible promissory notes. Upon conversion of the Notes in accordance with
the Notes or exercise of the Warrants in accordance with the Warrants, as the case may be, the Conversion Shares and the Warrant
Shares, respectively, will be validly issued, fully paid and nonassessable and free from all preemptive or similar rights, taxes,
liens and charges with respect to the issue thereof, with the holders being entitled to all rights accorded to a holder of Common
Stock. Assuming the accuracy of each of the representations and warranties set forth in Section 2 of this Agreement, the offer
and issuance by the Company of the Securities is exempt from registration under the 1933 Act.

 

(d)
No Conflicts. The execution, delivery and performance of the Transaction Documents by the Company and any of its Subsidiaries
parties to any of the Transaction Documents and the consummation by the Company and any of its Subsidiaries of the transactions
contemplated hereby and thereby (including, without limitation, the issuance of the Notes and the Warrants and reservation for
issuance and issuance of the Conversion Shares and the Warrant Shares) will not (i) result in a violation of the Certificate of
Incorporation (as defined in Section (3(q)) or Bylaws (as defined in Section (3(q)), any memorandum of association, certificate
of incorporation, certificate of formation, bylaws, any certificate of designations or other constituent documents of the Company
or any of its Subsidiaries, any capital stock of the Company or any of its Subsidiaries or the articles of association or bylaws
of the Company or any of its Subsidiaries or (ii) conflict with, or constitute a default (or an event which with notice or lapse
of time or both would become a default) in any respect under, or give to others any rights of termination, amendment, acceleration
or cancellation of, any material agreement, indenture or instrument to which the Company or any of its Subsidiaries is a party,
or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including other foreign, federal and state
securities laws and regulations and the rules and regulations of the OTCQB (the “Principal Market”) and including
all applicable laws of the State of Delaware and any foreign, federal and state laws, rules and regulations) applicable to the
Company or any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries is bound or affected.

 

    	 	- 8 -	 

     

    

 

(e)
Consents. Neither the Company nor any of its Subsidiaries is required to obtain any consent, authorization or order of,
or make any filing or registration with (other than the filing with the SEC of a Form D and any other filings as may be required
by any state securities agencies), any court, governmental agency or any regulatory or self-regulatory agency or any other Person
in order for it to execute, deliver or perform any of its obligations under or contemplated by the Transaction Documents, in each
case in accordance with the terms hereof or thereof. All consents, authorizations, orders, filings and registrations which the
Company or any of its Subsidiaries is required to obtain pursuant to the preceding sentence have been obtained or effected on
or prior to the Initial Closing Date, and the Company and its Subsidiaries are unaware of any facts or circumstances that might
prevent the Company or any of its Subsidiaries from obtaining or effecting any of the registration, application or filings pursuant
to the preceding sentence. The Company is not in violation of the listing requirements of the Principal Market and has no knowledge
of any facts that would reasonably lead to delisting or suspension of the Common Stock in the foreseeable future. The issuance
by the Company of the Securities shall not have the effect of delisting or suspending the Common Stock from the Principal Market.

 

(f)
Acknowledgment Regarding Buyer’s Purchase of Securities. The Company acknowledges and agrees that each Buyer is acting
solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated
hereby and thereby and that no Buyer is (i) an officer or director of the Company or any of its Subsidiaries, (ii) an “affiliate”
of the Company or any of its Subsidiaries (as defined in Rule 144) or (iii) to the knowledge of the Company, a “beneficial
owner” of more than 10% of the shares of Common Stock (as defined for purposes of Rule 13d-3 of the Securities Exchange
Act of 1934, as amended (the “1934 Act”)). The Company further acknowledges that no Buyer is acting as a financial
advisor or fiduciary of the Company or any of its Subsidiaries (or in any similar capacity) with respect to the Transaction Documents
and the transactions contemplated hereby and thereby, and any advice given by a Buyer or any of its representatives or agents
in connection with the Transaction Documents and the transactions contemplated hereby and thereby is merely incidental to such
Buyer’s purchase of the Securities. The Company further represents to each Buyer that the Company’s decision to enter
into the Transaction Documents has been based solely on the independent evaluation by the Company and its representatives.

 

(g)
No General Solicitation; Placement Agent’s Fees. Neither the Company, nor any of its Subsidiaries or affiliates,
nor any Person acting on its or their behalf, has engaged in any form of general solicitation or general advertising (within the
meaning of Regulation D) in connection with the offer or sale of the Securities. The Company shall be responsible for the payment
of any placement agent’s fees, financial advisory fees, or brokers’ commissions (other than for persons engaged by
any Buyer or its investment advisor) relating to or arising out of the transactions contemplated hereby, including, without limitation,
placement agent fees payable to J Streicher Capital, LLC (the “Placement Agent”) in connection with the sale
of the Securities. The Company shall pay, and hold each Buyer harmless against, any liability, loss or expense (including, without
limitation, attorney’s fees and out-of-pocket expenses) arising in connection with any such claim. The Company acknowledges
that it has engaged the Placement Agent in connection with the sale of the Securities. Other than the Placement Agent, neither
the Company nor any of its Subsidiaries has engaged any placement agent or other agent in connection with the sale of the Securities.

 

(h)
No Integrated Offering. None of the Company, its Subsidiaries, any of their affiliates, and any Person acting on their
behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under
circumstances that would require registration of any of the Securities under the 1933 Act, whether through integration with prior
offerings or otherwise, or cause this offering of the Securities to require approval of stockholders of the Company for purposes
of the 1933 Act or any applicable stockholder approval provisions, including, without limitation, under the rules and regulations
of any exchange or automated quotation system on which any of the securities of the Company are listed or designated. None of
the Company, its Subsidiaries, their affiliates and any Person acting on their behalf will take any action or steps referred to
in the preceding sentence that would require registration of any of the Securities under the 1933 Act or cause the offering of
the Securities to be integrated with other offerings for purposes of any such applicable stockholder approval provisions.

 

    	 	- 9 -	 

     

    

 

(i)
Application of Takeover Protections; Rights Agreement. The Company and its board of directors have taken all necessary
action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any
distribution under a rights agreement) or other similar anti-takeover provision under the Certificate of Incorporation or the
laws of the jurisdiction of its formation which is or could become applicable to any Buyer as a result of the transactions contemplated
by this Agreement, including, without limitation, the Company’s issuance of the Securities and any Buyer’s ownership
of the Securities. The Company has not adopted a stockholder rights plan or similar arrangement relating to accumulations of beneficial
ownership of Common Stock or a change in control of the Company.

 

(j)
SEC Documents; Financial Statements. Except as disclosed in Schedule 3(j), during the two (2) years prior to the
date hereof, the Company has timely filed all reports, schedules, forms, statements and other documents required to be filed by
it with the SEC pursuant to the reporting requirements of the 1934 Act (all of the foregoing filed prior to the date hereof, and
all exhibits included therein and financial statements, notes and schedules thereto and documents incorporated by reference therein
being hereinafter referred to as the “SEC Documents”). The Company has delivered to the Buyers or their respective
representatives true, correct and complete copies of the SEC Documents not available on the EDGAR system. As of their respective
filing dates, the SEC Documents complied in all material respects with the requirements of the 1934 Act and the rules and regulations
of the SEC promulgated thereunder applicable to the SEC Documents, and none of the SEC Documents, at the time they were filed
with the SEC, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.
As of their respective filing dates, the financial statements of the Company included in the SEC Documents complied as to form
in all material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect
thereto. Such financial statements have been prepared in accordance with generally accepted accounting principles, consistently
applied, during the periods involved (“GAAP”) (except (i) as may be otherwise indicated in such financial statements
or the notes thereto, or (ii) in the case of unaudited interim statements, to the extent they may exclude footnotes or may be
condensed or summary statements) and fairly present in all material respects the financial position of the Company as of the dates
thereof and the results of its operations and cash flows for the periods then ended (subject, in the case of unaudited statements,
to normal year-end audit adjustments). No other information provided by or on behalf of the Company to the Buyers which is not
included in the SEC Documents, including, without limitation, information referred to in Section 2(d) of this Agreement or in
the disclosure schedules to this Agreement, contains any untrue statement of a material fact or omits to state any material fact
necessary in order to make the statements therein, in the light of the circumstance under which they are or were made, not misleading.

 

(k)
Absence of Certain Changes. Except as disclosed in Schedule 3(k), since December 31, 2016, there has been no material
adverse change and no material adverse development in the business, assets, properties, operations, condition (financial or otherwise),
results of operations or prospects of the Company or its Subsidiaries. Except as disclosed in Schedule 3(k), since December
31, 2016, neither the Company nor any of its Subsidiaries has (i) declared or paid any dividends, (ii) sold any assets, individually
or in the aggregate, in excess of $100,000 outside of the ordinary course of business or (iii) had capital expenditures, individually
or in the aggregate, in excess of $100,000. Neither the Company nor any of its Subsidiaries has taken any steps to seek protection
pursuant to any bankruptcy law nor does the Company have any knowledge or reason to believe that its creditors intend to initiate
involuntary bankruptcy proceedings or any actual knowledge of any fact that would reasonably lead a creditor to do so.

 

    	 	- 10 -	 

     

    

 

(l)
No Undisclosed Events, Liabilities, Developments or Circumstances. No event, liability, development or circumstance has
occurred or exists, or is contemplated to occur with respect to the Company, its Subsidiaries or their respective business, properties,
prospects, operations or financial condition, that would be required to be disclosed by the Company under applicable securities
laws on a registration statement on Form S-1 filed with the SEC relating to an issuance and sale by the Company of its Common
Stock and which has not been publicly announced.

 

(m)
Conduct of Business; Regulatory Permits. Neither the Company nor any of its Subsidiaries is in violation of any term of
or in default under any certificate of designations of any outstanding series of preferred stock of the Company (if any), its
Certificate of Incorporation or Bylaws or their organizational charter or memorandum of association or certificate of incorporation
or articles of association or bylaws, respectively. Neither the Company nor any of its Subsidiaries is in violation of any judgment,
decree or order or any statute, ordinance, rule or regulation applicable to the Company or any of its Subsidiaries, and neither
the Company nor any of its Subsidiaries will conduct its business in violation of any of the foregoing, except for possible violations
which could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Without limiting
the generality of the foregoing, the Company is not in violation of any of the rules, regulations or requirements of the Principal
Market and has no knowledge of any facts or circumstances that would reasonably lead to delisting or suspension of the Common
Stock by the Principal Market in the foreseeable future. Except as set forth in Schedule 3(m), during the two (2) years
prior to the date hereof, the Common Stock has been designated for quotation on the Principal Market. Except as set forth in Schedule
3(m), during the two (2) years prior to the date hereof, (i) trading in the Common Stock has not been suspended by the SEC
or the Principal Market and (ii) the Company has received no communication, written or oral, from the SEC or the Principal Market
regarding the suspension of the Common Stock from the Principal Market. The Company and its Subsidiaries possess all certificates,
authorizations and permits issued by the appropriate federal, state or foreign regulatory authorities necessary to conduct their
respective businesses, except where the failure to possess such certificates, authorizations or permits would not have, individually
or in the aggregate, a Material Adverse Effect, and neither the Company nor any such Subsidiary has received any notice of proceedings
relating to the revocation or modification of any such certificate, authorization or permit.

 

(n)
Foreign Corrupt Practices. Neither the Company, nor any of its Subsidiaries, nor any director, officer, agent, employee
or other Person acting on behalf of the Company or any of its Subsidiaries has, in the course of its actions for, or on behalf
of, the Company or any of its Subsidiaries (i) used any corporate funds for any unlawful contribution, gift, entertainment or
other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any foreign or domestic
government official or employee from corporate funds; (iii) violated or is in violation of any provision of the U.S. Foreign Corrupt
Practices Act of 1977, as amended; or (iv) made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful
payment to any foreign or domestic government official or employee.

 

(o)
Sarbanes-Oxley Act. Except as disclosed in Schedule 3(o), the Company is in compliance with any and all applicable
requirements of the Sarbanes-Oxley Act of 2002, as amended, that are effective as of the date hereof, and any and all applicable
rules and regulations promulgated by the SEC thereunder that are effective as of the date hereof.

 

    	 	- 11 -	 

     

    

 

(p)
Transactions With Affiliates. Except as set forth on Schedule 3(p), none of the officers, directors or employees
of the Company or any of its Subsidiaries is presently a party to any transaction with the Company or any of its Subsidiaries
(other than for ordinary course services as employees, officers or directors), including any contract, agreement or other arrangement
providing for the furnishing of services to or by, providing for rental of real or personal property to or from, or otherwise
requiring payments to or from any such officer, director or employee or, to the knowledge of the Company or any of its Subsidiaries,
any corporation, partnership, trust or other entity in which any such officer, director, or employee has a substantial interest
or is an officer, director, trustee or partner.

 

(q)
Equity Capitalization. As of the Initial Closing Date, the authorized capital stock of the Company consists of (i) 200,000,000
shares of Common Stock, of which as of the date hereof, 4,081,393 shares are issued and outstanding, 709,876 shares are reserved
for issuance pursuant to the Company’s stock option and purchase plans, 5,684,603 shares are reserved for issuance upon
exercise of warrants outstanding and 4,374,624 shares are reserved for issuance pursuant to securities (other than the aforementioned
options, warrants and the Notes and the Warrants) exercisable or exchangeable for, or convertible into, Common Stock, (ii) 50,000,000
shares of preferred stock, par value $0.0001 per share, none of which are issued and outstanding as of the date hereof and (iii)
there are 2,776,367 shares of Common Stock held by non-affiliates of the Company. All of such outstanding shares have been, or
upon issuance will be, validly issued and are fully paid and nonassessable. Except as set forth in the SEC Documents or as disclosed
in Schedule 3(q), (i) none of the Company’s capital stock is subject to preemptive rights or any other similar rights
or any liens or encumbrances suffered or permitted by the Company; (ii) there are no outstanding options, warrants, scrip, rights
to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into, or exercisable
or exchangeable for, any shares of capital stock of the Company or any of its Subsidiaries, or contracts, commitments, understandings
or arrangements by which the Company or any of its Subsidiaries is or may become bound to issue additional shares of capital stock
of the Company or any of its Subsidiaries or options, warrants, scrip, rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities or rights convertible into, or exercisable or exchangeable for, any shares of capital stock
of the Company or any of its Subsidiaries; (iii) there are no outstanding debt securities, notes, credit agreements, credit facilities
or other agreements, documents or instruments evidencing Indebtedness of the Company or any of its Subsidiaries or by which the
Company or any of its Subsidiaries is or may become bound; (iv) there are no financing statements securing obligations in any
material amounts, either singly or in the aggregate, filed in connection with the Company or any of its Subsidiaries; (v) there
are no agreements or arrangements under which the Company or any of its Subsidiaries is obligated to register the sale of any
of their securities under the 1933 Act; (vi) there are no outstanding securities or instruments of the Company or any of its Subsidiaries
which contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by
which the Company or any of its Subsidiaries is or may become bound to redeem a security of the Company or any of its Subsidiaries;
(vii) there are no securities or instruments containing anti-dilution or similar provisions that will be triggered by the issuance
of the Securities; (viii) the Company does not have any stock appreciation rights or “phantom stock” plans or agreements
or any similar plan or agreement; and (ix) the Company and its Subsidiaries have no liabilities or obligations required to be
disclosed in the SEC Documents but not so disclosed in the SEC Documents, other than those incurred in the ordinary course of
the Company’s or any of its Subsidiary’s’ respective businesses and which, individually or in the aggregate,
do not or would not have a Material Adverse Effect. The Company has furnished or made available to the Buyers true, correct and
complete copies of the Company’s Certificate of Incorporation, as amended and as in effect on the date hereof (the “Certificate
of Incorporation”), and the Company’s Bylaws, as amended and as in effect on the date hereof (the “Bylaws”),
and the terms of all securities convertible into, or exercisable or exchangeable for shares of Common Stock and the material rights
of the holders thereof in respect thereto.

 

    	 	- 12 -	 

     

    

 

(r)
Indebtedness and Other Contracts. Except as disclosed on Schedule 3(r), neither the Company nor any of its Subsidiaries
(i) has any outstanding Indebtedness (as defined below), (ii) is a party to any contract, agreement or instrument, the violation
of which, or default under which, by the other party(ies) to such contract, agreement or instrument could reasonably be expected
to result in a Material Adverse Effect, (iii) is in violation of any term of or in default under any contract, agreement or instrument
relating to any Indebtedness, except where such violations and defaults would not result, individually or in the aggregate, in
a Material Adverse Effect, or (iv) is a party to any contract, agreement or instrument relating to any Indebtedness, the performance
of which, in the judgment of the Company’s officers, has or is expected to have a Material Adverse Effect. Schedule 3(r)
provides a detailed description of the material terms of any such outstanding Indebtedness. For purposes of this Agreement:
(x) “Indebtedness” of any Person means, without duplication (A) all indebtedness for borrowed money, (B) all
obligations issued, undertaken or assumed as the deferred purchase price of property or services, including, without limitation,
“capital leases” in accordance with GAAP (other than trade payables entered into in the ordinary course of business
consistent with past practice), (C) all reimbursement or payment obligations with respect to letters of credit, surety bonds and
other similar instruments, (D) all obligations evidenced by notes, bonds, debentures or similar instruments, including obligations
so evidenced incurred in connection with the acquisition of property, assets or businesses, (E) all indebtedness created or arising
under any conditional sale or other title retention agreement, or incurred as financing, in either case with respect to any property
or assets acquired with the proceeds of such indebtedness (even though the rights and remedies of the seller or bank under such
agreement in the event of default are limited to repossession or sale of such property), (F) all monetary obligations under any
leasing or similar arrangement which, in connection with GAAP, consistently applied for the periods covered thereby, is classified
as a capital lease, (G) all indebtedness referred to in clauses (A) through (F) above secured by (or for which the holder of such
Indebtedness has an existing right, contingent or otherwise, to be secured by) any mortgage, lien, pledge, charge, security interest
or other encumbrance upon or in any property or assets (including accounts and contract rights) owned by any Person, even though
the Person which owns such assets or property has not assumed or become liable for the payment of such indebtedness, and (H) all
Contingent Obligations in respect of indebtedness or obligations of others of the kinds referred to in clauses (A) through (G)
above; and (y) “Contingent Obligation” means, as to any Person, any direct or indirect liability, contingent
or otherwise, of that Person with respect to any Indebtedness, lease, dividend or other obligation of another Person if the primary
purpose or intent of the Person incurring such liability, or the primary effect thereof, is to provide assurance to the obligee
of such liability that such liability will be paid or discharged, or that any agreements relating thereto will be complied with,
or that the holders of such liability will be protected (in whole or in part) against loss with respect thereto.

 

(s)
Absence of Litigation. There is no action, suit, proceeding, inquiry or investigation before or by the Principal Market,
any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company,
threatened against or affecting the Company or any of its Subsidiaries, the Common Stock or any of the Company’s Subsidiaries
or any of the Company’s or its Subsidiaries’ officers or directors, whether of a civil or criminal nature or otherwise,
in their capacities as such, except as set forth in Schedule 3(s). The matters set forth in Schedule 3(s) would
not reasonably be expected to have a Material Adverse Effect.

 

(t)
Insurance. The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against
such losses and risks and in such amounts as management of the Company believes to be prudent and customary in the businesses
in which the Company and its Subsidiaries are engaged. Neither the Company nor any such Subsidiary has been refused any insurance
coverage sought or applied for and neither the Company nor any such Subsidiary has any reason to believe that it will not be able
to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers
as may be necessary to continue its business at a cost that would not have a Material Adverse Effect.

 

    	 	- 13 -	 

     

    

 

(u)
Employee Relations.

 

(i)
Neither the Company nor any of its Subsidiaries is a party to any collective bargaining agreement or employs any member of a union.
The Company and its Subsidiaries believe that their relations with their employees are good. No executive officer (as defined
in Rule 501(f) under the 1933 Act) of the Company or any of its Subsidiaries has notified the Company or any such Subsidiary that
such officer intends to leave the Company or any such Subsidiary or otherwise terminate such officer’s employment with the
Company or any such Subsidiary. No executive officer of the Company or any of its Subsidiaries, to the knowledge of the Company
or any of its Subsidiaries, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality,
disclosure or proprietary information agreement, non-competition agreement, or any other contract or agreement or any restrictive
covenant, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries
to any liability with respect to any of the foregoing matters.

 

(ii)
The Company and its Subsidiaries are in compliance with all federal, state, local and foreign laws and regulations respecting
labor, employment and employment practices and benefits, terms and conditions of employment and wages and hours, except where
failure to be in compliance would not, either individually or in the aggregate, reasonably be expected to result in a Material
Adverse Effect.

 

(v)
Title. The Company and its Subsidiaries have good and marketable title in fee simple to all real property and good and
marketable title to all personal property owned by them which is material to the business of the Company and its Subsidiaries,
in each case free and clear of all liens, encumbrances and defects except for Permitted Liens which do not materially affect the
value of such property and do not interfere with the use made and proposed to be made of such property by the Company and any
of its Subsidiaries. Any real property and facilities held under lease by the Company and any of its Subsidiaries are held by
them under valid, subsisting and enforceable leases with such exceptions as are not material and do not interfere with the use
made and proposed to be made of such property and buildings by the Company and its Subsidiaries.

 

(w)
Intellectual Property Rights. The Company and its Subsidiaries own or possess adequate rights or licenses to use all trademarks,
trade names, service marks, service mark registrations, service names, original works of authorship, patents, patent rights, copyrights,
inventions, licenses, approvals, governmental authorizations, trade secrets and other intellectual property rights and all applications
and registrations therefor (“Intellectual Property Rights”) necessary to conduct their respective businesses
as now conducted. None of the Company’s Intellectual Property Rights have expired or terminated or have been abandoned or
are expected to expire or terminate or are expected to be abandoned, within three years from the date of this Agreement. The Company
does not have any knowledge of any infringement by the Company or its Subsidiaries of Intellectual Property Rights of others.
There is no claim, action or proceeding being made or brought, or to the knowledge of the Company or any of its Subsidiaries,
being threatened, against the Company or any of its Subsidiaries regarding its Intellectual Property Rights. Neither the Company
nor any of its Subsidiaries is aware of any facts or circumstances that might give rise to any of the foregoing infringements
or claims, actions or proceedings. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy,
confidentiality and value of all of their Intellectual Property Rights.

 

    	 	- 14 -	 

     

    

 

(x)
Environmental Laws. Except as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse
Effect: (i) neither the Company nor its Subsidiaries is in violation of any Environmental Laws (as hereinafter defined), (ii)
the Company and its Subsidiaries have received all permits, licenses or other approvals required of them under applicable Environmental
Laws to conduct their respective businesses and (iii) the Company and its Subsidiaries are in compliance with all terms and conditions
of any such permit, license or approval. The term “Environmental Laws” means all federal, state, local or foreign
laws relating to pollution or protection of human health or the environment (including, without limitation, ambient air, surface
water, groundwater, land surface or subsurface strata), including, without limitation, laws relating to emissions, discharges,
releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively,
“Hazardous Materials”) into the environment, or otherwise relating to the manufacture, processing, distribution,
use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees,
demands or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations
issued, entered, promulgated or approved thereunder.

 

(y)
Subsidiary Rights. The Company or one of its Subsidiaries has the unrestricted right to vote, and (subject to limitations
imposed by applicable law) to receive dividends and distributions on, all capital securities of its Subsidiaries as owned by the
Company or such Subsidiary.

 

(z)
Investment Company Status. Neither the Company nor any Subsidiary is, and upon consummation of the sale of the Securities,
and for so long any Buyer holds any Securities, will be, an “investment company,” a company controlled by an “investment
company” or an “affiliated person” of, or “promoter” or “principal underwriter” for,
an “investment company” as such terms are defined in the Investment Company Act of 1940, as amended.

 

(aa)
Tax Status. The Company and each of its Subsidiaries (i) has made or filed all U.S. federal, state and foreign income and
all other tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes
and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns,
reports and declarations, except those being contested in good faith and (iii) has set aside on its books provision
reasonably adequate for the payment of all taxes for periods subsequent to the periods to which such returns, reports or
declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any
jurisdiction, and the officers of the Company know of no basis for any such claim.

 

(bb)
Internal Accounting and Disclosure Controls. Except as set forth in Schedule 3(bb) or as set forth in the SEC Documents,
the Company and each of its Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance
that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles
and to maintain asset and liability accountability, (iii) access to assets or incurrence of liabilities is permitted only in accordance
with management’s general or specific authorization and (iv) the recorded accountability for assets and liabilities is compared
with the existing assets and liabilities at reasonable intervals and appropriate action is taken with respect to any difference.
Except as set forth in Schedule 3(bb) or as set forth in the SEC Documents, the Company maintains disclosure controls and
procedures (as such term is defined in Rule 13a-15 under the 1934 Act) that are effective in ensuring that information required
to be disclosed by the Company in the reports that it files or submits under the 1934 Act is recorded, processed, summarized and
reported, within the time periods specified in the rules and forms of the SEC, including, without limitation, controls and procedures
designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the
1934 Act is accumulated and communicated to the Company’s management, including its principal executive officer or officers
and its principal financial officer or officers, as appropriate, to allow timely decisions regarding required disclosure.

 

    	 	- 15 -	 

     

    

 

(cc)
Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company and an
unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and
is not so disclosed or that otherwise would be reasonably likely to have a Material Adverse Effect.

 

(dd)
Ranking of Notes. Except as set forth in Schedule 3(dd), no Indebtedness of the Company or any of its Subsidiaries
is senior to or ranks pari passu with the Notes in right of payment, whether with respect of payment of redemptions, interest,
damages or upon liquidation or dissolution or otherwise.

 

(ee)
Transfer Taxes. On each Closing Date, all stock transfer or other taxes (other than income or similar taxes) that are
required to be paid in connection with the sale and transfer of the Securities to be sold to each Buyer hereunder will be, or
will have been, fully paid or provided for by the Company, and all laws imposing such taxes will be or will have been
complied with.

 

(ff)
Manipulation of Price. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or
indirectly, any action designed to cause or to result, or that could reasonably be expected to cause or result, in the stabilization
or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) other
than the Placement Agent, sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities,
or (iii) other than the Placement Agent, paid or agreed to pay to any person any compensation for soliciting another to purchase
any other securities of the Company.

 

(gg)
Acknowledgement Regarding Buyers’ Trading Activity. The Company acknowledges and agrees that (i) none of the Buyers
has been asked to agree, nor has any Buyer agreed, to desist from purchasing or selling, long and/or short, securities of the
Company, or “derivative” securities based on securities issued by the Company or to hold the Securities for any specified
term; (ii) any Buyer, and counter-parties in “derivative” transactions to which any such Buyer is a party, directly
or indirectly, presently may have a “short” position in the Common Stock, and (iii) each Buyer shall not be deemed
to have any affiliation with or control over any arm’s length counter-party in any “derivative” transaction.
The Company further understands and acknowledges that one or more Buyers may engage in hedging and/or trading activities at various
times during the period that the Securities are outstanding and (b) such hedging and/or trading activities, if any, can reduce
the value of the existing stockholders’ equity interest in the Company both at and after the time the hedging and/or trading
activities are being conducted. The Company acknowledges that such aforementioned hedging and/or trading activities do not constitute
a breach of this Agreement, the Notes, the Warrants or any of the documents executed in connection herewith.

 

(hh)
U.S. Real Property Holding Corporation. The Company is not, has never been, and so long as any Securities remain outstanding,
shall not become, a U.S. real property holding corporation within the meaning of Section 897 of the Code and the Company shall
so certify upon any Buyer’s request.

 

    	 	- 16 -	 

     

    

 

(ii)
Bank Holding Company Act. Neither the Company nor any of its Subsidiaries or affiliates is subject to the Bank Holding
Company Act of 1956, as amended (the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve
System (the “Federal Reserve”). Neither the Company nor any of its Subsidiaries or affiliates owns or controls,
directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent
(25%) or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.
Neither the Company nor any of its Subsidiaries or affiliates exercises a controlling influence over the management or policies
of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.

 

(jj)
No Additional Agreements. Neither the Company nor any of its Subsidiaries has any agreement or understanding with any Buyer
with respect to the transactions contemplated by the Transaction Documents other than as specified in the Transaction Documents.

 

(kk)
Disclosure. Except for the transaction contemplated hereby, the Company confirms that neither it nor any other Person acting
on its behalf has provided any of the Buyers or their agents or counsel with any information that constitutes or could reasonably
be expected to constitute material, nonpublic information. The Company understands and confirms that each of the Buyers will rely
on the foregoing representations in effecting transactions in securities of the Company. All disclosure provided to the Buyers
regarding the Company, or any of its Subsidiaries, their business and the transactions contemplated hereby, including the disclosure
schedules to this Agreement, furnished by or on behalf of the Company is true and correct and does not contain any untrue statement
of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of
the circumstances under which they were made, not misleading. Each press release issued by the Company or any of its Subsidiaries
during the twelve (12) months preceding the date of this Agreement did not at the time of release contain any untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading. No event or circumstance has occurred or
information exists with respect to the Company or any of its Subsidiaries or its or their business, properties, prospects, operations
or financial conditions, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company
but which has not been so publicly announced or disclosed. The Company acknowledges and agrees that no Buyer makes or has made
any representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth
in Section 2.

 

(ll)
Shell Company Status. The Company is not, and has not been since July 14, 2013, an issuer identified in Rule 144(i)(1)
of the 1933 Act. As of July 14, 2013, the Company filed current “Form 10 information” (as defined in Rule 144 (i)(3))
with the SEC reflecting its status as an entity that was no longer an issuer described in Rule 144(i)(1)(i).

 

(mm)
Stock Option Plans. Each stock option granted by the Company was granted (i) in accordance with the terms of the applicable
stock option plan of the Company and (ii) with an exercise price at least equal to the fair market value of the Common Stock on
the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company’s
stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no policy or practice
of the Company to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with,
the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial
results or prospects.

 

(nn)
No Disagreements with Accountants and Lawyers. There are no material disagreements of any kind presently existing, or reasonably
anticipated by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the
Company. In addition, on or prior to the date hereof, the Company had discussions with its accountants about its financial statements
previously filed with the SEC. Based on those discussions, the Company has no reason to believe that it will need to restate any
such financial statements or any part thereof.

 

    	 	- 17 -	 

     

    

 

(oo)
No Disqualification Events. Except as set forth in Schedule 3(oo), with respect to Securities to be offered and
sold hereunder in reliance on Rule 506(b) under the 1933 Act (“Regulation D Securities”), none of the Company,
any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating in
the offering hereunder, any beneficial owner of 20% or more of the Company’s outstanding voting equity securities, calculated
on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the 1933 Act) connected with the Company
in any capacity at the time of sale (each, an “Issuer Covered Person” and, together, “Issuer Covered
Persons”) is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii)
under the 1933 Act (a “Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2)
or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification
Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished
to the Buyers a copy of any disclosures provided thereunder.

 

(pp)
Other Covered Persons. The Company is not aware of any Person (other than the Placement Agent) that has been or will be
paid (directly or indirectly) remuneration for solicitation of Buyers or potential purchasers in connection with the sale of any
Securities.

 

4.
COVENANTS.

 

(a)
Best Efforts. Each party shall use its best efforts timely to satisfy each of the covenants and the conditions to be satisfied
by it as provided in Sections 6 and 7 of this Agreement.

 

(b)
Form D and Blue Sky. The Company agrees to file a Form D with respect to the Securities as required under Regulation D
and to provide a copy thereof to each Buyer promptly after such filing. The Company shall, on or before each Closing Date, take
such action as the Company shall reasonably determine is necessary in order to obtain an exemption for or to qualify the Securities
for sale to the Buyers at such Closing pursuant to this Agreement under applicable securities or “Blue Sky” laws of
the states of the United States (or to obtain an exemption from such qualification), and shall provide evidence of any such action
so taken to the Buyers on or prior to the applicable Closing Date. The Company shall make all filings and reports relating to
the offer and sale of the Securities required under applicable securities or “Blue Sky” laws of the states of the
United States following the applicable Closing Date.

 

(c)
Reporting Status. Until the date on which the Buyers shall have sold all of the Conversion Shares and Warrant Shares and
none of the Notes or Warrants are outstanding (the “Reporting Period”), the Company shall timely file all reports
required to be filed with the SEC pursuant to the 1934 Act, and the Company shall not terminate its status as an issuer required
to file reports under the 1934 Act even if the 1934 Act or the rules and regulations thereunder would no longer require or otherwise
permit such termination.

 

(d)
Use of Proceeds. The Company will use the proceeds from the sale of the Securities solely for working capital and general
corporate purposes.

 

    	 	- 18 -	 

     

    

 

(e)
Financial Information. The Company agrees to send the following to each Buyer during the Reporting Period (i) unless the
following are filed with the SEC through EDGAR and are available to the public through the EDGAR system, within one (1) Business
Day after the filing thereof with the SEC, a copy of its Annual Reports on Form 10-K, any Quarterly Reports on Form 10-Q, any
Current Reports on Form 8-K (or any analogous reports under the 1934 Act) and any registration statements (other than on Form
S-8) or amendments filed pursuant to the 1933 Act, (ii) unless the following are filed with the SEC through EDGAR and are available
to the public through the EDGAR system, on the same day as the release thereof, facsimile or e-mailed copies of all press releases
issued by the Company or any of its Subsidiaries, and (iii) copies of any notices and other information made available or given
to the stockholders of the Company generally, contemporaneously with the making available or giving thereof to the stockholders.
As used herein, “Business Day” means any day other than Saturday, Sunday or other day on which commercial banks
in The City of New York are authorized or required by law to remain closed.

 

(f)
[Reserved].

 

(g)
Transfer Agent. For so long any Securities are outstanding, the Company shall cause its transfer agent to participate in
the Depository Trust Company Fast Automated Securities Transfer Program.

 

(h)
Fees. The Company shall reimburse Empery (a Buyer) or its designee(s) (in addition to any other expense amounts paid to
any Buyer or its counsel prior to the date of this Agreement) for all costs and expenses incurred in connection with the transactions
contemplated by the Transaction Documents (including all legal fees and disbursements in connection therewith, documentation and
implementation of the transactions contemplated by the Transaction Documents and due diligence in connection therewith) (hereinafter,
collectively, the “Empery Expenses”), which amount may be withheld by such Buyer from its purchase price for
any Notes purchased at the Initial Closing to the extent not previously reimbursed by the Company. Notwithstanding the foregoing,
in no event will the Empery Expenses reimbursed by the Company pursuant to this Section 4(h) exceed $10,000 without the prior
approval from the Company. In addition, with respect to all costs and expenses owed by the Company to a Buyer, including, without
limitation, unpaid collateral agent fees, unpaid interest or other unpaid fees and expenses, such Buyer may withhold such amount
from its Purchase Price for any Notes purchased at the Closing. The Company shall be responsible for the payment of any placement
agent’s fees, financial advisory fees, or broker’s commissions (other than for Persons engaged by any Buyer) relating
to or arising out of the transactions contemplated hereby, including, without limitation, any fees or commissions payable to the
Placement Agent. The Company shall pay, and hold each Buyer harmless against, any liability, loss or expense (including, without
limitation, reasonable attorney’s fees and out-of-pocket expenses) arising in connection with any claim relating to any
such payment. Except as otherwise set forth in the Transaction Documents, each party to this Agreement shall bear its own expenses
in connection with the sale of the Securities to the Buyers.

 

(i)
Pledge of Securities. The Company acknowledges and agrees that the Securities may be pledged by a Buyer in connection with
a bona fide margin agreement or other loan or financing arrangement that is secured by the Securities. The pledge of Securities
shall not be deemed to be a transfer, sale or assignment of the Securities hereunder, and no Buyer effecting a pledge of Securities
shall be required to provide the Company with any notice thereof or otherwise make any delivery to the Company pursuant to this
Agreement or any other Transaction Document, including, without limitation, Section 2(f) hereof; provided that a Buyer
and its pledgee shall be required to comply with the provisions of Section 2(f) hereof in order to effect a sale, transfer or
assignment of Securities to such pledgee. The Company hereby agrees to execute and deliver such documentation as a pledgee of
the Securities may reasonably request in connection with a pledge of the Securities to such pledgee by a Buyer.

 

    	 	- 19 -	 

     

    

 

(j)
Disclosure of Transactions and Other Material Information. On or before 8:30 a.m., New York City time, on November 2, 2017,
(i) the Company shall issue a press release reasonably acceptable to the Buyers and (ii) file a Current Report on Form 8-K describing
the terms of the transactions contemplated by the Transaction Documents in the form required by the 1934 Act and attaching the
material Transaction Documents (including, without limitation, this Agreement (and all schedules and exhibits to this Agreement),
the form of Notes, the form of the Warrants and the Security Documents as exhibits to such filing (including all attachments,
the “8-K Filing”). Subject to the foregoing, neither the Company, its Subsidiaries nor any Buyer shall issue
any press releases or any other public statements with respect to the transactions contemplated hereby; provided, however, that
the Company shall be entitled, without the prior approval of any Buyer, to make any press release or other public disclosure with
respect to such transactions (i) in substantial conformity with the 8-K Filing and contemporaneously therewith and (ii) as is
required by applicable law and regulations (provided that in the case of clause (i) each Buyer shall be consulted by the Company
in connection with any such press release or other public disclosure prior to its release). Without the prior written consent
of any applicable Buyer, neither the Company nor any of its Subsidiaries or affiliates shall disclose the name of such Buyer in
its capacity as a Buyer in any filing, announcement, release or otherwise.

 

(k) Additional
Notes; Variable Securities. So long as any Buyer beneficially owns any Notes, the Company will not issue any Notes
(other than to the Buyers as contemplated hereby), and the Company shall not issue any other securities that would cause a
breach or default under the Notes; provided, however, the Company may amend its outstanding Indebtedness to
provide for the approved issuance of these Notes and adjust any relevant terms accordingly. For so long as any Notes remain
outstanding, the Company shall not, in any manner, issue or sell any rights, warrants or options to subscribe for or purchase
Common Stock or directly or indirectly convertible into or exchangeable or exercisable for Common Stock at a price which
varies or may vary with the market price of the Common Stock, including by way of one or more reset(s) to any fixed price
unless the conversion, exchange or exercise price of any such security cannot be less than the then applicable Conversion
Price (as defined in the Notes) with respect to the Common Stock into which any Note is convertible or the then applicable
Exercise Price (as defined in the Warrants) with respect to the Common Stock into which any Warrant is
exercisable.

 

(l)
Corporate Existence. So long as any Buyer beneficially owns any Securities, the Company shall (i) maintain its corporate
existence and (ii) not be party to any Fundamental Transaction (as defined in the Notes) unless the Company is in compliance with
the applicable provisions governing Fundamental Transactions set forth in the Notes and the Warrants.

 

(m)
Reservation of Shares. So long as any Buyer owns any Securities, the Company shall take all action necessary to at all
times have authorized, and reserved for the purpose of issuance, no less than the Required Reserve Amount. If at any time the
number of shares of Common Stock authorized and reserved for issuance is not sufficient to meet the Required Reserved Amount,
the Company will promptly take all corporate action necessary to authorize and reserve a sufficient number of shares, including,
without limitation, calling a special meeting of stockholders to authorize additional shares to meet the Company’s obligations
under Section 3(c), in the case of an insufficient number of authorized shares, obtain stockholder approval of an increase in
such authorized number of shares, and voting the management shares of the Company in favor of an increase in the authorized shares
of the Company to ensure that the number of authorized shares is sufficient to meet the Required Reserved Amount.

 

    	 	- 20 -	 

     

    

 

(n)
Conduct of Business. The business of the Company and its Subsidiaries shall not be conducted in violation of any law, ordinance
or regulation of any governmental entity, except where such violations would not result, either individually or in the aggregate,
in a Material Adverse Effect.

 

(o)
Public Information. At any time during the period commencing from the six (6) month anniversary of the Initial Closing
Date and ending at such time that all of the Securities, if a registration statement is not available for the resale of all of
the Securities, may be sold without restriction or limitation pursuant to Rule 144 and without the requirement to be in compliance
with Rule 144(c)(1), if the Company shall (i) fail for any reason to satisfy the requirements of Rule 144(c)(1), including, without
limitation, the failure to satisfy the current public information requirement under Rule 144(c) or (ii) if the Company has ever
been an issuer described in Rule 144(i)(1)(i) or becomes such an issuer in the future, and the Company shall fail to satisfy any
condition set forth in Rule 144(i)(2) (a “Public Information Failure”) then, as partial relief for the damages
to any holder of Securities by reason of any such delay in or reduction of its ability to sell the Securities (which remedy shall
not be exclusive of any other remedies available at law or in equity), the Company shall pay to each such holder an amount in
cash equal to two percent (2.0%) of the aggregate Purchase Price of such holder’s Securities on the day of a Public Information
Failure and on every thirtieth day (pro rated for periods totaling less than thirty days) thereafter until the earlier of (i)
the date such Public Information Failure is cured and (ii) such time that such public information is no longer required pursuant
to Rule 144. The payments to which a holder shall be entitled pursuant to this Section 4(o) are referred to herein as “Public
Information Failure Payments.” Public Information Failure Payments shall be paid on the earlier of (I) the last day
of the calendar month during which such Public Information Failure Payments are incurred and (II) the third Business Day after
the event or failure giving rise to the Public Information Failure Payments is cured. In the event the Company fails to make Public
Information Failure Payments in a timely manner, such Public Information Failure Payments shall bear interest at the rate of 1.5%
per month (prorated for partial months) until paid in full.

 

(p)
Notice of Disqualification Events. The Company will notify the Buyers in writing, prior to the applicable Closing Date
of (i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time,
become a Disqualification Event relating to any Issuer Covered Person.

 

(q)
Collateral Agent.

 

(i)
Each Buyer hereby (a) appoints Empery Tax Efficient, LP as the collateral agent hereunder and under the Security Documents (in
such capacity, the “Collateral Agent”), and (b) authorizes the Collateral Agent (and its officers, directors,
employees and agents) to take such action on such Buyer’s behalf in accordance with the terms hereof and thereof. The Collateral
Agent shall not have, by reason hereof or pursuant to any Security Documents, a fiduciary relationship in respect of any Buyer.
Neither the Collateral Agent nor any of its officers, directors, employees and agents shall have any liability to any Buyer for
any action taken or omitted to be taken in connection hereof or the Security Documents except to the extent caused by its own
gross negligence or willful misconduct, and each Buyer agrees to defend, protect, indemnify and hold harmless the Collateral Agent
and all of its officers, directors, employees and agents (collectively, the “Collateral Agent Indemnitees”)
from and against any losses, damages, liabilities, obligations, penalties, actions, judgments, suits, fees, costs and expenses
(including, without limitation, reasonable attorneys’ fees, costs and expenses) incurred by such Collateral Agent Indemnitee,
whether direct, indirect or consequential, arising from or in connection with the performance by such Collateral Agent Indemnitee
of the duties and obligations of Collateral Agent pursuant hereto or any of the Security Documents.

 

    	 	- 21 -	 

     

    

 

(ii)
The Collateral Agent shall be entitled to rely upon any written notices, statements, certificates, orders or other documents or
any telephone message believed by it in good faith to be genuine and correct and to have been signed, sent or made by the proper
Person, and with respect to all matters pertaining to this Agreement or any of the other Transaction Documents and its duties
hereunder or thereunder, upon advice of counsel selected by it.

 

(iii)
The Collateral Agent may resign from the performance of all its functions and duties hereunder and under the Notes and the Security
Documents at any time by giving at least ten (10) Business Days prior written notice to the Company and each holder of the Notes.
Such resignation shall take effect upon the acceptance by a successor Collateral Agent of appointment as provided below. Upon
any such notice of resignation, the holders of a majority of the outstanding principal amount of Notes shall appoint a successor
Collateral Agent. Upon the acceptance of the appointment as Collateral Agent, such successor Collateral Agent shall succeed to
and become vested with all the rights, powers, privileges and duties of the retiring Collateral Agent, and the retiring Collateral
Agent shall be discharged from its duties and obligations under this Agreement, the Notes and the Security Agreement. After any
Collateral Agent’s resignation hereunder, the provisions of this Section 4(q) shall inure to its benefit. If a successor
Collateral Agent shall not have been so appointed within said ten (10) Business Day period, the retiring Collateral Agent shall
then appoint a successor Collateral Agent who shall serve until such time, if any, as the holders of a majority of the outstanding
principal amount of Notes appoints a successor Collateral Agent as provided above.

 

(iv)
The Company hereby covenants and agrees to take all actions as promptly as practicable reasonably requested by either the holders
of a majority of the outstanding principal amount of Notes or the Collateral Agent (or its successor), from time to time pursuant
to the terms of this Section 4(q), to secure a successor Collateral Agent satisfactory to such requesting part(y)(ies), in their
sole discretion, including, without limitation, by paying all fees of such successor Collateral Agent, by having the Company agree
to indemnify any successor Collateral Agent and by each of the Company executing a collateral agency agreement or similar agreement
and/or any amendment to the Security Documents reasonably requested or required by the successor Collateral Agent.

 

(v)The
Company agrees to pay the Collateral Agent, by wire transfer of immediately available funds in accordance with the Collateral
Agent’s written wire instructions, a quarterly agency fee of $10,000 within three (3) Business Days following the end of
each calendar quarter that the Collateral Agent acted as collateral agent in accordance with this Section 4(q) and the Security
Documents during such calendar quarter, provided, such fee shall be non-duplicative to any existing fee arrangements with
the Collateral Agent arising from existing Indebtedness.

 

(r)
Closing Documents. On or prior to November 15, 2017, the Company agrees to deliver, or cause to be delivered, to each Buyer
a complete closing set of the executed Transaction Documents, Securities and any other documents relating to the Subsequent Closing
required to be delivered to any party pursuant to Section 7(b) hereof or otherwise.

 

(s)
Pledges of Intellectual Property Rights. The Company hereby agrees that it shall not pledge, mortgage, encumber or otherwise
permit the Intellectual Property Rights to be subject to any lien, security interest, encumbrances, or charge (such actions hereinafter
referred to collectively as “Pledge”) any of its Intellectual Property Rights except for Pledges related to
current commercial development agreements as listed on Schedule 4(s) or for future commercial development agreements entered
into in the ordinary course of business. The Company hereby further agrees: (a) to promptly notify the Collateral Agent of any
such future commercial development agreements (but only if the Collateral Agent executes a confidentiality agreement with respect
to any material, non-public information regarding or related to such commercial development agreements prior to its receipt of
any such material, non-public information), and (b) to amend Schedule 4(s) in connection with such additional Pledges,
with the approval of the Collateral Agent, which approval shall not be unreasonably withheld.

 

    	 	- 22 -	 

     

    

 

5.
REGISTER; TRANSFER AGENT INSTRUCTIONS.

 

(a)
Register. The Company shall maintain at its principal executive offices (or such other office or agency of the Company
as it may designate by notice to each holder of Securities), a register for the Notes and the Warrants in which the Company shall
record the name and address of the Person in whose name the Notes and the Warrants have been issued (including the name and address
of each transferee), the principal amount of Notes held by such Person, the number of Conversion Shares issuable pursuant to the
terms of the Notes and the number of Warrant Shares issuable upon exercise of the Warrants held by such Person. The Company shall
keep the register open and available at all times during business hours for inspection of any Buyer or its legal representatives.

 

(b)
Transfer Agent Instructions. The Company shall issue irrevocable instructions to its transfer agent, and any subsequent
transfer agent, in the form of Exhibit E attached hereto (the “Irrevocable Transfer Agent Instructions”)
to issue certificates or credit shares to the applicable balance accounts at DTC, registered in the name of each Buyer or its
respective nominee(s), for the Conversion Shares and Warrant Shares issued at each Closing or pursuant to the terms of the Notes
or exercise of the Warrants in such amounts as specified from time to time by each Buyer to the Company upon conversion of the
Notes or exercise of the Warrants. The Company warrants that no instruction other than the Irrevocable Transfer Agent Instructions
referred to in this Section 5(b), and stop transfer instructions to give effect to Section 2(f) hereof, will be given by the Company
to its transfer agent, and that the Securities shall otherwise be freely transferable on the books and records of the Company
as and to the extent provided in this Agreement and the other Transaction Documents. If a Buyer effects a sale, assignment or
transfer of the Securities in accordance with Section 2(f), the Company shall permit the transfer and shall promptly instruct
its transfer agent to issue one or more certificates or credit shares to the applicable balance accounts at DTC in such name and
in such denominations as specified by such Buyer to effect such sale, transfer or assignment. In the event that such sale, assignment
or transfer involves the Conversion Shares or Warrant Shares sold, assigned or transferred pursuant to an effective registration
statement or pursuant to Rule 144, the transfer agent shall issue such Securities to the Buyer, assignee or transferee, as the
case may be, without any restrictive legend. The Company acknowledges that a breach by it of its obligations hereunder will cause
irreparable harm to a Buyer. Accordingly, the Company acknowledges that the remedy at law for a breach of its obligations under
this Section 5(b) will be inadequate and agrees, in the event of a breach or threatened breach by the Company of the provisions
of this Section 5(b), that a Buyer shall be entitled, in addition to all other available remedies, to an order and/or injunction
restraining any breach and requiring immediate issuance and transfer, without the necessity of showing economic loss and without
any bond or other security being required.

 

    	 	- 23 -	 

     

    

 

6.
CONDITIONS TO THE COMPANY’S OBLIGATION TO SELL.

 

(a)
The obligation of the Company hereunder to issue and sell the Initial Notes and the related Initial Warrants to each Initial Buyer
at the Initial Closing was subject to the satisfaction, at or before the Initial Closing Date, of each of the following conditions,
provided that these conditions are for the Company’s sole benefit and could have been waived by the Company at any
time in its sole discretion by providing each Buyer with prior written notice thereof:

 

(i)
Such Initial Buyer shall have executed each of the Transaction Documents to which it is a party and the Investor Questionnaire
and delivered the same to the Company.

 

(ii)
Such Initial Buyer shall have executed and delivered to the Company the flow of funds memorandum (“Flow of Funds”),
confirming the Initial Purchase Price payable by such Initial Buyer and the wiring instructions applicable thereto.

 

(iii)
Such Initial Buyer shall have delivered its Initial Purchase Price to the Company for the Initial Notes and Initial Warrants purchased
by such Initial Buyer at the Initial Closing by wire transfer of immediately available funds pursuant to the wire instructions
provided by the Company provided, if the Initial Buyer is directed to wire its funds to a third party pursuant to the Flow
of Funds, the receipt of funds by such designated third party shall constitute delivery of its Purchase Price, in part or in whole
as indicated in the Flow of Funds, hereunder.

 

(iv)
The representations and warranties of such Initial Buyer shall be true and correct in all material respects (except for those
representations and warranties that are qualified by materiality or material adverse effect, which shall be true and correct in
all respects) as of the date when made and as of the Initial Closing Date as though made at that time (except for representations
and warranties that speak as of a specific date which shall be true and correct as of such specified date), and such Initial Buyer
shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by
this Agreement to be performed, satisfied or complied with by such Initial Buyer at or prior to the Initial Closing Date.

 

(b)
The obligation of the Company hereunder to issue and sell the Subsequent Notes and the related Subsequent Warrants to each Subsequent
Buyer at the Subsequent Closing is subject to the satisfaction, at or before the Subsequent Closing Date, of each of the following
conditions, provided that these conditions are for the Company’s sole benefit and may be waived by the Company at
any time in its sole discretion by providing each Subsequent Buyer with prior written notice thereof:

 

(i)
Such Subsequent Buyer shall have executed the Investor Questionnaire and delivered the same to the Company.

 

(ii)
Such Subsequent Buyer shall have executed either (x) a Joinder Agreement or (y) a Subsequent Closing Notice and delivered the
same to the Company.

 

(iii)
Such Subsequent Buyer shall have delivered its Subsequent Purchase Price to the Company for the Subsequent Notes and the Subsequent
Warrants being purchased by such Subsequent Buyer at the Subsequent Closing by wire transfer of immediately available funds pursuant
to the wire instructions provided by the Company.

 

(iv)
The representations and warranties of such Subsequent Buyer shall be true and correct in all material respects (except for those
representations and warranties that are qualified by materiality or material adverse effect, which shall be true and correct in
all respects) as of the date when made and as of the Subsequent Closing Date as though made at that time (except for representations
and warranties that speak as of a specific date which shall be true and correct as of such specified date), and such Subsequent
Buyer shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required
by this Agreement to be performed, satisfied or complied with by such Subsequent Buyer at or prior to the Subsequent Closing Date.

 

    	 	- 24 -	 

     

    

 

7.
CONDITIONS TO EACH BUYER’S OBLIGATION TO PURCHASE.

 

(a)
The obligation of each Initial Buyer hereunder to purchase the Initial Notes and Initial Warrants at the Initial Closing was subject
to the satisfaction, at or before the Initial Closing Date, of each of the following conditions, provided that these conditions
are for each Initial Buyer’s sole benefit and could have been waived by such Initial Buyer at any time in its sole discretion
by providing the Company with prior written notice thereof:

 

(i)
The Company and each of its Subsidiaries shall have duly executed and delivered to such Initial Buyer each of the following documents
to which it is a party: (A) each of the Transaction Documents, and (B) the Initial Notes (allocated in such principal amounts
as such Initial Buyer shall request) and the related Initial Warrants, in each case being purchased by such Initial Buyer at the
Initial Closing pursuant to this Agreement.

 

(ii)
The Company shall have delivered to such Initial Buyer a copy of the Irrevocable Transfer Agent Instructions, in the form of Exhibit
E attached hereto, which instructions shall have been delivered to and acknowledged in writing by the Company’s transfer
agent.

 

(iii)
The Company shall have delivered to such Initial Buyer a certificate evidencing the formation and good standing of the Company
and each of its Subsidiaries in such entity’s jurisdiction of formation issued by the Secretary of State (or comparable
office) of such jurisdiction, as of a date within ten (10) days of the Initial Closing Date.

 

(iv)
The Company shall have delivered to such Initial Buyer a certificate evidencing the Company’s and each of its Subsidiaries’
qualification as a foreign corporation and good standing issued by the Secretary of State (or comparable office) of each jurisdiction
in which the Company and its Subsidiaries conduct business, as of a date within ten (10) days of the Initial Closing Date.

 

(v)
The Company shall have delivered to such Initial Buyer a certificate, executed by the Secretary of the Company and dated as of
the Initial Closing Date, as to (i) the resolutions consistent with Section 3(b) as adopted by the Company’s and each of
its Subsidiaries’ Board of Directors in a form reasonably acceptable to such Initial Buyer, (ii) the Certificate of Incorporation
of the Company and each of its Subsidiaries and (iii) the Bylaws of the Company and each of its Subsidiaries, each as in effect
at the Initial Closing, in the form attached hereto as Exhibit F.

 

(vi)
The representations and warranties of the Company shall be true and correct in all material respects (except for those representations
and warranties that are qualified by materiality or Material Adverse Effect, which shall be true and correct in all respects)
as of the date when made and as of the Initial Closing Date as though made at that time (except for representations and warranties
that speak as of a specific date which shall be true and correct as of such specified date) and the Company shall have performed,
satisfied and complied in all respects with the covenants, agreements and conditions required by the Transaction Documents to
be performed, satisfied or complied with by the Company at or prior to the Initial Closing Date. Such Initial Buyer shall have
received a certificate, executed by the Chief Executive Officer of the Company, dated as of the Initial Closing Date, to the foregoing
effect and as to such other matters as may be reasonably requested by such Initial Buyer in the form attached hereto as Exhibit
G.

 

    	 	- 25 -	 

     

    

 

(vii)
The Common Stock (I) shall be designated for quotation on the Principal Market and (II) shall not have been suspended, as of the
Initial Closing Date, by the SEC or the Principal Market from quotation on the Principal Market nor shall suspension by the SEC
or the Principal Market have been threatened, as of the Initial Closing Date, in writing by the SEC or the Principal Market.

 

(viii)
The Company shall have obtained all governmental, regulatory or third party consents and approvals, if any, necessary for the
sale of the Securities.

 

(ix)
Each of the Company’s Subsidiaries shall have executed and delivered to such Initial Buyer the Guaranty Amendment.

 

(x)
The Collateral Agent shall have received (x) the Second Amendment to the Subordination and Intercreditor Agreement, in the form
attached as Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the SEC on September 20, 2017 (the “September
Subordination Amendment”), which further amends that certain Subordination and Intercreditor Agreement dated as of September
1, 2016 by and among Longboard Capital Advisors LLC, the Company, Ener-Core Power, Inc., Anthony Tang, as a Senior Lender (as
defined therein) and Empery Tax Efficient, LP in its capacity as collateral agent for the Senior Note Lenders (as defined therein),
as amended to date, and (x) the Second Amendment to the Subordination and Intercreditor Agreement, in the form attached as Exhibit
10.2 to the Company’s Current Report on Form 8-K filed with the SEC on September 20, 2017 (the “October Subordination
Amendment”), which further amends that certain Subordination and Intercreditor Agreement dated as of November 2, 2015
by and among Anthony Tang, the Company and Empery Tax Efficient, LP in its capacity as collateral agent for the Senior Lenders
(as defined therein), as amended to date, in each case, duly executed and delivered by all parties thereto.

 

(xi)
The Collateral Agent shall have received the Security Amendment Agreement, duly executed by the Company and each of its Subsidiaries,
together with the original stock certificates representing all of the equity interests and all promissory notes required to be
pledged thereunder, accompanied by undated stock powers and allonges executed in blank and other proper instruments of transfer.

 

(xii)
The Company shall have delivered to such Initial Buyer such other documents relating to the transactions contemplated by this
Agreement as such Initial Buyer or its counsel may reasonably request.

 

(b)
The obligation of each Subsequent Buyer hereunder to purchase the Subsequent Notes and the related Subsequent Warrants at the
Subsequent Closing is subject to the satisfaction, at or before the Subsequent Closing Date, of each of the following conditions,
provided that these conditions are for each Subsequent Buyer’s sole benefit and may be waived by such Subsequent Buyer at
any time in its sole discretion by providing the Company with prior written notice thereof:

 

(i)
The Company and each of its Subsidiaries shall have duly executed and delivered to such Subsequent Buyer each of the following
documents to which it is a party: (A) each of the Transaction Documents, and (B) the Subsequent Notes (allocated in such principal
amounts as such Subsequent Buyer shall request) and the related Subsequent Warrants, in each case being purchased by such Subsequent
Buyer at the Subsequent Closing pursuant to this Agreement.

 

    	 	- 26 -	 

     

    

 

(ii)
If applicable, the Company shall have duly executed and delivered to such Subsequent Buyer the Joinder Agreement of such Subsequent
Buyer.

 

(iii)
The Company shall have delivered to such Subsequent Buyer a copy of the Irrevocable Transfer Agent Instructions, in the form of
Exhibit E attached hereto, which instructions shall have been delivered to and acknowledged in writing by the Company’s
transfer agent.

 

(iv)
The Company shall have delivered to such Subsequent Buyer a certificate evidencing the formation and good standing of the Company
and each of its Subsidiaries in such entity’s jurisdiction of formation issued by the Secretary of State (or comparable
office) of such jurisdiction, as of a date within ten (10) days of the Initial Closing Date, and a bringdown of such certificate(s)
as of a date within ten (10) days of the Subsequent Closing Date.

 

(v)
The Company shall have delivered to such Subsequent Buyer a certificate evidencing the Company’s and each of its Subsidiaries’
qualification as a foreign corporation and good standing issued by the Secretary of State (or comparable office) of each jurisdiction
in which the Company and its Subsidiaries conduct business, as of a date within ten (10) days of the Initial Closing Date, and
a bringdown of such certificate(s) as of a date within ten (10) days of the Subsequent Closing Date.

 

(vi)
The Company shall have delivered to such Subsequent Buyer a certificate, executed by the Secretary of the Company and dated as
of the Initial Closing Date, as to (i) the resolutions consistent with Section 3(b) as adopted by the Company’s and each
of its Subsidiaries’ Board of Directors in a form reasonably acceptable to such Subsequent Buyer, (ii) the Certificate of
Incorporation of the Company and each of its Subsidiaries and (iii) the Bylaws of the Company and each of its Subsidiaries, each
as in effect at the Subsequent Closing, in the form attached hereto as Exhibit F.

 

(vii)
The representations and warranties of the Company shall be true and correct in all material respects (except for those representations
and warranties that are qualified by materiality or Material Adverse Effect, which shall be true and correct in all respects)
as of the date when made and as of the Subsequent Closing Date as though made at that time (except for representations and warranties
that speak as of a specific date which shall be true and correct as of such specified date) and the Company shall have performed,
satisfied and complied in all respects with the covenants, agreements and conditions required by the Transaction Documents to
be performed, satisfied or complied with by the Company at or prior to the Subsequent Closing Date. Such Subsequent Buyer shall
have received a certificate, executed by the Chief Executive Officer of the Company, dated as of the Subsequent Closing Date,
to the foregoing effect and as to such other matters as may be reasonably requested by such Subsequent Buyer in the form attached
hereto as Exhibit G.

 

(viii)
The Common Stock (I) shall be designated for quotation on the Principal Market and (II) shall not have been suspended, as of the
Subsequent Closing Date, by the SEC or the Principal Market from quotation on the Principal Market nor shall suspension by the
SEC or the Principal Market have been threatened, as of the Subsequent Closing Date, in writing by the SEC or the Principal Market.

 

    	 	- 27 -	 

     

    

 

(ix)
The Company shall have obtained all governmental, regulatory or third party consents and approvals, if any, necessary for the
sale of the Securities.

 

(x)
Each of the Company’s Subsidiaries shall have executed and delivered to such Subsequent Buyer the Guaranty Amendment.

 

(xi)
The Company shall have delivered to such Subsequent Buyer such other documents relating to the transactions contemplated by this
Agreement as such Subsequent Buyer or its counsel may reasonably request.

 

8.
MISCELLANEOUS.

 

(a)
Governing Law; Jurisdiction; Jury Trial. All questions concerning the construction, validity, enforcement and interpretation
of this Agreement shall be governed by the internal laws of the State of New York, without giving effect to any choice of law
or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application
of the laws of any jurisdictions other than the State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and
agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any
such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or
proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being served
in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained
herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. EACH PARTY HEREBY IRREVOCABLY
WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION
WITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

(b)
Counterparts. This Agreement may be executed in two or more identical counterparts, all of which shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other
party; provided that a facsimile or “.pdf” electronic format signature shall be considered due execution and shall
be binding upon the signatory thereto with the same force and effect as if the signature were an original, not a facsimile or
“.pdf” electronic format signature.

 

(c)
Headings. The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation
of, this Agreement.

 

(d)
Severability. If any provision of this Agreement is prohibited by law or otherwise determined to be invalid or unenforceable
by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed
amended to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such
provision shall not affect the validity of the remaining provisions of this Agreement so long as this Agreement as so modified
continues to express, without material change, the original intentions of the parties as to the subject matter hereof and the
prohibited nature, invalidity or unenforceability of the provision(s) in question does not substantially impair the respective
expectations or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred
upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s)
with a valid provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable
provision(s).

 

    	 	- 28 -	 

     

    

 

(e)
Entire Agreement; Amendments. This Agreement and the other Transaction Documents supersede all other prior oral or written
agreements between the Buyers, the Company, their affiliates and Persons acting on their behalf with respect to the matters discussed
herein, and this Agreement, the other Transaction Documents and the instruments referenced herein and therein contain the entire
understanding of the parties with respect to the matters covered herein and therein and, except as specifically set forth herein
or therein, neither the Company nor any Buyer makes any representation, warranty, covenant or undertaking with respect to such
matters. Provisions of this Agreement may be amended and the observance thereof may be waived (either generally or in a particular
instance and either retroactively or prospectively), only with the written consent of the Company and the holders of at least
a majority of the aggregate number of the Conversion Shares issued or issuable under the Notes (calculated using the Initial Conversion
Price) and Warrants Shares issued or issuable pursuant to the Warrants (without regard to any limitation on conversion or exercise
set forth therein) and shall include Empery so long as Empery or any of its affiliates holds any Securities (the “Required
Holders”); provided that any such amendment or waiver that complies with the foregoing but that disproportionately,
materially and adversely affects the rights and obligations of any Buyer relative to the comparable rights and obligations of
the other Buyers shall require the prior written consent of such adversely affected Buyer; provided, further, that
the provisions of Section 4(q) cannot be amended without the additional prior written approval of the Collateral Agent or its
successor. Any amendment or waiver effected in accordance with this Section 8(e) shall be binding upon each Buyer and holder of
Securities and the Company. No such amendment shall be effective to the extent that it applies to less than all of the Buyers
or holders of Securities. No consideration shall be offered or paid to any Person to amend or consent to a waiver or modification
of any provision of any of the Transaction Documents unless the same consideration (other than the reimbursement of legal fees)
also is offered to all of the parties to the Transaction Documents, holders of Notes, or holders of the Warrants as the case may
be. The Company has not, directly or indirectly, made any agreements with any Buyers relating to the terms or conditions of the
transactions contemplated by the Transaction Documents except as set forth in the Transaction Documents. Without limiting the
foregoing, the Company confirms that, except as set forth in this Agreement, no Buyer has made any commitment or promise or has
any other obligation to provide any financing to the Company or otherwise.

 

(f)
Notices. Any notices, consents, waivers or other communications required or permitted to be given under the terms of this
Agreement must be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon
receipt, when sent by facsimile (provided confirmation of transmission is mechanically or electronically generated and kept on
file by the sending party); (iii) upon receipt, if sent by e-mail (provided that such sent e-mail is kept on file (whether electronically
or otherwise) by the sending party and the sending party does not immediately receive an automatically generated message from
the recipient’s e-mail server that such e-mail could not be delivered to such recipient) or (iv) one Business Day after
deposit with an overnight courier service, in each case properly addressed to the party to receive the same. The addresses, facsimile
numbers and e-mail addresses for such communications shall be:

 

If
to the Company:

 

Ener-Core,
Inc.

8965
Research Drive, Suite 100

Irvine,
California 92618 

Telephone:
      (949) 616-3333

Facsimile:
        (949) 616-3399

Attention:
        Mr. Domonic J. Carney, CFO 

Email:
              DJ.Carney@ener-core.com

 

    	 	- 29 -	 

     

    

 

With
a copy (for informational purposes only) to:

 

K&L
Gates LLP

1
Park Plaza, 12th Floor

Irvine
CA 92614

Telephone:
      (949) 623-3545

Facsimile:
       (949) 623-4477

Attention:
        Shoshannah D. Katz, Esq.

Email:
             shoshannah.katz@klgates.com

 

If
to the Transfer Agent:

 

VStock
Transfer, LLC.

18
Lafayette Place 

Woodmere,
New York 11598

Telephone:
      (212) 828-8436

Facsimile:
       (646) 536-3179

Attention:
        Yoel Goldfeder

E-mail:
            yoel@vstocktransfer.com

 

If
to a Buyer, to its address, facsimile number and e-mail address set forth on the Schedule of Buyers, with copies to such Buyer’s
representatives as set forth on the Schedule of Buyers,

 

or
to such other address, facsimile number and/or e-mail address and/or to the attention of such other Person as the recipient party
has specified by written notice given to each other party five (5) days prior to the effectiveness of such change. Written confirmation
of receipt (A) given by the recipient of such notice, consent, waiver or other communication, (B) mechanically or electronically
generated by the sender’s facsimile machine or e-mail containing the time, date, recipient facsimile number and an image
of the first page of such transmission or (C) provided by an overnight courier service shall be rebuttable evidence of personal
service, receipt by facsimile or receipt from an overnight courier service in accordance with clause (i), (ii) or (iv) above,
respectively. A copy of the e-mail transmission containing the time, date and recipient e-mail address shall be rebuttable evidence
of receipt by e-mail in accordance with clause (iii) above.

 

(g)
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their respective
successors and assigns, including any purchasers of the Notes and the Warrants. The Company shall not assign this Agreement or
any rights or obligations hereunder without the prior written consent of the Required Holders, including by way of a Fundamental
Transaction (unless the Company is in compliance with the applicable provisions governing Fundamental Transactions set forth in
the Notes and the Warrants). A Buyer may assign some or all of its rights hereunder without the consent of the Company, in which
event such assignee shall be deemed to be a Buyer hereunder with respect to such assigned rights.

 

    	 	- 30 -	 

     

    

 

(h)
No Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted
successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except that
each Indemnitee shall have the right to enforce the obligations of the Company with respect to Section 8(k).

 

(i)
Survival. The representations and warranties of the Company and the Buyers contained in Sections 2 and 3, and the agreements
and covenants set forth in Sections 4, 5 and 8 shall survive each Closing. Each Buyer shall be responsible only for its own representations,
warranties, agreements and covenants hereunder.

 

(j)
Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things,
and shall execute and deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably
request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions
contemplated hereby, including without limitation taking such reasonable action as is necessary or desirable to perfect a security
interest in the Company’s or one or more of its Subsidiaries’ Intellectual Property. Also, without limiting the generality
of the requirements of the Company set forth in the Transaction Documents, the Company hereby covenants and agrees to provide
prompt notice to the Collateral Agent upon the issuance of any patents in the name of the Company or any of their Subsidiaries
anywhere in the world.

 

(k)
Indemnification.

 

(i)
In consideration of each Buyer’s execution and delivery of the Transaction Documents and acquiring the Securities thereunder
and in addition to all of the Company’s other obligations under the Transaction Documents, the Company shall defend, protect,
indemnify and hold harmless each Buyer and each other holder of the Securities and all of their stockholders, partners, members,
officers, directors, employees and direct or indirect investors and any of the foregoing Persons’ agents or other representatives
(including, without limitation, those retained in connection with the transactions contemplated by this Agreement) (collectively,
the “Indemnitees”) from and against any and all actions, causes of action, suits, claims, losses, costs, penalties,
fees, liabilities and damages, and expenses in connection therewith (irrespective of whether any such Indemnitee is a party to
the action for which indemnification hereunder is sought), and including reasonable attorneys’ fees and disbursements (the
“Indemnified Liabilities”), incurred by any Indemnitee as a result of, or arising out of, or relating to (a)
any misrepresentation or breach of any representation or warranty made by the Company in the Transaction Documents or any other
certificate, instrument or document contemplated hereby or thereby, (b) any breach of any covenant, agreement or obligation of
the Company contained in the Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby
or (c) any cause of action, suit or claim brought or made against such Indemnitee by a third party (including for these purposes
a derivative action brought on behalf of the Company) and arising out of or resulting from (i) the execution, delivery, performance
or enforcement of the Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby, (ii)
any transaction financed or to be financed in whole or in part, directly or indirectly, with the proceeds of the issuance of the
Securities, (iii) any disclosure made by such Buyer pursuant to Section 4(j), or (iv) the status of such Buyer or holder of the
Securities as an investor in the Company pursuant to the transactions contemplated by the Transaction Documents. To the extent
that the foregoing undertaking by the Company may be unenforceable for any reason, the Company shall make the maximum contribution
to the payment and satisfaction of each of the Indemnified Liabilities that is permissible under applicable law.

 

    	 	- 31 -	 

     

    

 

(ii)
Promptly after receipt by an Indemnitee under this Section 8(k) of notice of the commencement of any action or proceeding (including
any governmental action or proceeding) involving an Indemnified Liability, such Indemnitee shall, if a claim for indemnification
in respect thereof is to be made against any indemnifying party under this Section 8(k), deliver to the indemnifying party a written
notice of the commencement thereof, and the indemnifying party shall have the right to participate in, and, to the extent the
indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume control of the defense thereof
with counsel mutually satisfactory to the indemnifying party and the Indemnitee; provided, however, that an Indemnitee shall have
the right to retain its own counsel with the fees and expenses of not more than one counsel for such Indemnitee to be paid by
the indemnifying party, if, in the reasonable opinion of the Indemnitee, the representation by such counsel of the Indemnitee
and the indemnifying party would be inappropriate due to actual or potential differing interests between such Indemnitee and any
other party represented by such counsel in such proceeding. Legal counsel referred to in the immediately preceding sentence shall
be selected by the Buyer holding at least a majority of the aggregate principal amount of the Notes. The Indemnitee shall cooperate
fully with the indemnifying party in connection with any negotiation or defense of any such action or Indemnified Liabilities
by the indemnifying party and shall furnish to the indemnifying party all information reasonably available to the Indemnitee that
relates to such action or Indemnified Liabilities. The indemnifying party shall keep the Indemnitee fully apprised at all times
as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying party shall be liable for
any settlement of any action, claim or proceeding effected without its prior written consent, provided, however, that the indemnifying
party shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the prior written
consent of the Indemnitee, which consent shall not be unreasonably withheld conditioned or delayed, consent to entry of any judgment
or enter into any settlement or other compromise which (i) does not include as an unconditional term thereof the giving by the
claimant or plaintiff to such Indemnitee of a release from all liability in respect to such Indemnified Liabilities or litigation,
(ii) requires any admission of wrongdoing by such Indemnitee, or (iii) obligates or requires an Indemnitee to take, or refrain
from taking, any action. Following indemnification as provided for hereunder, the indemnifying party shall be subrogated to all
rights of the Indemnitee with respect to all third parties, firms or corporations relating to the matter for which indemnification
has been made. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of
any such action shall not relieve such indemnifying party of any liability to the Indemnitee under this Section 8(k), except to
the extent that the indemnifying party is prejudiced in its ability to defend such action.

 

(iii)
The indemnification required by this Section 8(k) shall be made by periodic payments of the amount thereof during the course of
the investigation or defense, as and when bills are received or Indemnified Liabilities are incurred.

 

(iv)
The indemnity agreements contained herein shall be in addition to (x) any cause of action or similar right of the Indemnitee against
the indemnifying party or others, and (y) any liabilities the indemnifying party may be subject to pursuant to the law.

 

(l)
No Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to
express their mutual intent, and no rules of strict construction will be applied against any party.

 

    	 	- 32 -	 

     

    

 

(m)
Remedies. Each Buyer and each holder of the Securities shall have all rights and remedies set forth in the Transaction
Documents and all rights and remedies which such holders have been granted at any time under any other agreement or contract and
all of the rights which such holders have under any law. Any Person having any rights under any provision of this Agreement shall
be entitled to enforce such rights specifically (without posting a bond or other security), to recover damages by reason of any
breach of any provision of this Agreement and to exercise all other rights granted by law. Furthermore, the Company recognizes
that in the event that it fails to perform, observe, or discharge any or all of its obligations under the Transaction Documents,
any remedy at law may prove to be inadequate relief to the Buyers. The Company therefore agrees that the Buyers shall be entitled
to seek temporary and permanent injunctive relief in any such case without the necessity of proving actual damages and without
posting a bond or other security.

 

(n)
Rescission and Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any similar
provisions of) the Transaction Documents, whenever any Buyer exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Buyer
may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand
or election in whole or in part without prejudice to its future actions and rights.

 

(o)
Payment Set Aside. To the extent that the Company makes a payment or payments to the Buyers hereunder or pursuant to any
of the other Transaction Documents or the Buyers enforce or exercise their rights hereunder or thereunder, and such payment or
payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent
or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company,
a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, foreign, state or federal
law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally
intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such
enforcement or setoff had not occurred.

 

(p)
Independent Nature of Buyers’ Obligations and Rights. The obligations of each Buyer under any Transaction Document
are several and not joint with the obligations of any other Buyer, and no Buyer shall be responsible in any way for the performance
of the obligations of any other Buyer under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Buyer pursuant hereto or thereto, shall be deemed to constitute the Buyers as, and the Company acknowledges
that the Buyers do not so constitute, a partnership, an association, a joint venture or any other kind of entity, or create a
presumption that the Buyers are in any way acting in concert or as a group, and the Company shall not assert any such claim with
respect to such obligations or the transactions contemplated by the Transaction Documents and the Company acknowledges that the
Buyers are not acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction
Documents. The Company acknowledges and each Buyer confirms that it has independently participated in the negotiation of the transaction
contemplated hereby with the advice of its own counsel and advisors. Each Buyer shall be entitled to independently protect and
enforce its rights, including, without limitation, the rights arising out of this Agreement or out of any other Transaction Documents,
and it shall not be necessary for any other Buyer to be joined as an additional party in any proceeding for such purpose.

 

[Signature
Pages Follow]

 

    	 	- 33 -	 

     

    

 

IN
WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this Amended and Restated Securities
Purchase Agreement to be duly executed as of the date first written above.

 

	 	COMPANY:
	 	 
	 	ENER-CORE,
    INC.
	 	 	 
	 	By:	 
	 	 	Name:
    Alain J. Castro
	 	 	Title:
    Chief Executive Officer 

 

Signature
Page to Amended and Restated Securities Purchase Agreement 

 

     

     

    

  

IN
WITNESS WHEREOF, each Buyer and the Company have caused their respective signature page to this Amended and Restated Securities
Purchase Agreement to be duly executed as of the date first written above.

 

	 	INITIAL
    BUYER:
	 	 	 
	 	By:	 
	 	 	Name:
    
	 	 	Title:

 

Signature
Page to Amended and Restated Securities Purchase Agreement

 

     

     

    

 

SCHEDULE
OF BUYERS

 

	(1)	 	(2)	 	(3)	 	(4)	 	(5)	 	(6)
	Buyer	 	Address and
 Facsimile Number	 	Aggregate
 Principal
 Amount of Notes	 	Number of Warrant Shares	 	Purchase Price	 	Legal Representative’s Address and Facsimile Number
	 	 	 	 	 	 	 	 	 	 	 
	
TOTAL
	 	 	 	$555,555.56	 	222,222	 	$500,000.00	 	 

  

     

     

    

 

EXHIBITS

 

	Exhibit
    A	Form of Notes
	Exhibit B	Form of Warrant
	Exhibit C	Form of Joinder Agreement
	Exhibit D	Form of Investor Questionnaire
	Exhibit E	Form of Irrevocable Transfer Agent Instructions
	Exhibit F	Form of Secretary’s Certificate
	Exhibit G	Form of Officer’s Certificate

 

SCHEDULES

 

	Schedule
    3(a)	Subsidiaries
	Schedule
    3(j)	SEC Documents
	Schedule
    3(m)	Regulatory Permits
	Schedule
    3(o)	Sarbanes-Oxley Act
	Schedule
    3(p)	Transactions with Affiliates
	Schedule
    3(q)	Equity Capitalization
	Schedule
    3(r)	Indebtedness and Other Contracts
	Schedule
    3(s)	Absence of Litigation
	Schedule
    3(bb)	Internal Accounting and Disclosure Controls
	Schedule
    3(dd)	Ranking of Notes
	Schedule
    3(nn)	No Disagreements with Accountants and Lawyers
	Schedule
    3(oo)	No Disqualification Events
	Schedule
    4(s)	Pledges of Intellectual Property Rights

 

     

     

    

 

EXHIBIT
A

 

Form
of Notes

 

[Omitted]

 

     

     

    

 

EXHIBIT
B

 

Form
of Warrant

 

[Omitted]

 

     

     

    

 

EXHIBIT
C

 

Form
of Joinder Agreement

 

     

     

    

 

JOINDER
AGREEMENT

 

Reference
is hereby made to that certain Securities Purchase Agreement by and among Ener-Core, Inc., a Delaware corporation, with headquarters
located at 8965 Research Drive, Irvine, California 92618 (the “Company”), and the Initial Buyers (as defined
therein), dated as of September 19, 2017, as amended and restated on November 1, 2017 and attached hereto as Exhibit A
(as amended and/or restated to date, the “Securities Purchase Agreement”). Capitalized terms not defined herein
shall be as defined in the Securities Purchase Agreement.

 

(a)
The party signatory hereto as the “Subsequent Buyer” (the “Subsequent Buyer”) desires to purchase
a Subsequent Note and Subsequent Warrant for the Subsequent Purchase Price, as set forth under the signature line of the Subsequent
Buyer attached hereto. The date of the Subsequent Closing (the “Subsequent Closing Date”) shall occur on the
date hereof.

 

(b)
The Subsequent Buyer acknowledges, represents and warrants that it has reviewed the Securities Purchase Agreement, and subject
to the satisfaction (or waiver) of the conditions of Sections 1(c), 6(b) and 7(b), as of the Subsequent Closing Date, the Subsequent
Buyer shall be a “Buyer” and a “Subsequent Buyer”, in each case as defined in the Securities Purchase
Agreement, with all the rights and obligations of a “Buyer” and a “Subsequent Buyer” set forth therein.

 

(c)
Having read the representations in Section 2 of the Securities Purchase Agreement, the Subsequent Buyer hereby makes the representations
and warranties contained in Section 2 of the Securities Purchase Agreement, as set forth therein, to the Company as of the date
hereof and as of the Subsequent Closing Date.

 

(d)
With regards to the Company’s representations and warranties in Section 3 of the Securities Purchase Agreement, the Company
hereby makes the representations and warranties contained in Section 3 of the Securities Purchase Agreement, as set forth therein,
to the Subsequent Buyer as of the date hereof and as of the Subsequent Closing Date, as modified or affected by the schedules
attached to the Securities Purchase Agreement.

 

(e)
The Subsequent Buyer has executed and delivered to the Company an investor questionnaire, substantially in the form attached hereto
as Attachment 1, which such Subsequent Buyer represents and warrants is true, correct and complete. The Subsequent Buyer
agrees to furnish the Company with any additional information it reasonably requests to ensure compliance with applicable federal
and state securities laws in connection with the purchase of the Subsequent Note and Subsequent Warrant.

 

(f)
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to the other party; provided that a
facsimile or “.pdf” electronic format signature shall be considered due execution and shall be binding upon the signatory
thereto with the same force and effect as if the signature were an original, not a facsimile or “.pdf” electronic
format signature.

 

(g)
All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the
internal laws of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether
of the State of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than
the State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting
in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with
any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit,
action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action
or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party
hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that such service
shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit
in any way any right to serve process in any manner permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY
HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT
OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

[Signature
Page Follows]

     

     

    

 

IN
WITNESS WHEREOF, the Subsequent Buyer and the Company have caused their respective signature page to this Agreement to be
duly executed, in counterparts, as of the date set forth below.

 

	 	SUBSEQUENT
    BUYER:
	 	 	 
	 	By:	 
	 	 	Name:
    
	 	 	Title:
    
	 	 
	 	 
	 	Aggregate
    Principal Amount of Subsequent Note Purchased:
	 	 
	 	Number
    of Subsequent Warrant Shares:
	 	 
	 	Subsequent
    Purchase Price:
	 	 
	 	 
	 	Address:
	 	 
	 	 
	 	 
	 	 
	 	Attention:
	 	 
	 	 
	 	Facsimile:
	 	 
	 	 
	 	Telephone:
	 	 
	 	 
	 	Email:
	 	 

 

Accepted
by:

 

	 	COMPANY:	 
	 	 	 
	 	ENER-CORE,
    INC.	 
	 	 	 	 
	 	By:	 	 
	 	 	Name:
    Alain J. Castro	 
	 	 	Title:
    Chief Executive Officer	 

 

Signature
Page to Joinder Agreement 

 

     

     

    

 

EXHIBITS

 

	Exhibit
    A:	Securities Purchase Agreement
	Attachment
    1:	Investor Questionnaire

  

     

     

    

 

EXHIBIT
A

 

Securities
Purchase Agreement

 

[Omitted]

 

     

     

    

 

ATTACHMENT
1

 

Investor
Questionnaire

 

[Omitted]

 

     

     

    

 

EXHIBIT
D

 

Form
of Investor Questionnaire

 

     

     

    

 

Ener-Core,
Inc.

 

ACCREDITED
INVESTOR QUESTIONNAIRE

 

PLEASE
READ CAREFULLY

 

This
investor questionnaire is being submitted by the undersigned to Ener-Core, Inc., a Delaware corporation (“Issuer”)
in order to determine whether the undersigned qualifies as an “accredited investor” under Regulation D promulgated
under the Securities Act of 1933 (the “Securities Act”). The undersigned understands that Issuer will rely
upon the accuracy and completeness of the information provided in this questionnaire in determining whether certain issuances
of securities of Issuer may qualify for an exemption from the registration requirements of the Securities Act. Please return your
completed questionnaire and executed signature page hereto with your signature page to the Securities Purchase Agreement.

 

I. Accredited
Investor: The undersigned hereby represents and warrants that the undersigned is an “accredited
investor” under Regulation D promulgated under the Securities Act. ☐  (please check box if you are an
accredited investor)

 

The
undersigned is an “accredited investor” for one of the following reasons (check whichever applies):

 

Individuals.
If the undersigned is a natural person (ignoring any revocable grantor trust), then the undersigned hereby represents and
warrants as follows (check whichever applies):

 

	 	☐	The
    undersigned is a director, executive officer, or general partner of the Issuer, or a director, executive officer, or general
    partner of a general partner of the Issuer.

 

	 	☐	The
    undersigned has a net worth (either individually or jointly with the undersigned’s spouse) in excess of $1,000,000 (see
    calculation guidance below).

 

	 	☐	The
    undersigned (i) either (A) had an individual annual income (exclusive of spousal income) in excess of $200,000 or (B) had
    a joint income with the undersigned’s spouse in excess of $300,000 in each of the two preceding tax years, and (ii)
    reasonably expects to have the same income level (individually or jointly, as applicable) in the current tax year (see
    calculation guidance below).

 

The
term “net worth” means the excess of total assets over total liabilities. In calculating “net worth,”
the Investor must exclude the value of the Investor’s principal residence as an asset. The value of the principal residence
should be calculated as the fair market value of the residence, less any debt secured by such residence. To the extent that the
amount of debt secured by the primary residence exceeds the fair market value of such residence, this excess amount of debt should
be considered a liability for purposes of calculating net worth. The term “individual income” means adjusted
gross income, as reported for federal income tax purposes, less any income attributable to a spouse or property owned by a spouse,
increased by the amount (if not attributable to a spouse or property owned by a spouse) of any tax-exempt shares received, losses
claimed as a partner in an entity treated as a partnership for tax purposes, any deduction claimed for depletion, any deduction
for long term capital gains. The term “joint income” is defined in the same manner as “individual income,”
except that income attributable to a spouse or property owned by a spouse is included.

 

     

     

    

 

Trusts.
If the undersigned is a trust, then the undersigned hereby represents and warrants that the undersigned is (check whichever
applies):

 

	 	☐	A
    revocable trust (such as a living trust) or a trust formed for the purpose of acquiring the securities and for which, in either
    case, each grantor is an accredited investor. Indicate each grantor and the category that describes how each such grantor
    itself is qualified as an “accredited investor”:
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	☐	A
    trust which has total assets in excess of $5,000,000, not formed for the specific purpose of acquiring securities, whose purchase
    is directed by a “sophisticated person” within the meaning of Regulation D who has such knowledge and experience
    in financial and business matters as to be capable of evaluating the merits and risks of an investment in the proposed investment.

 

Entities.
If the undersigned is a corporation, partnership, limited liability company or trust, then the undersigned hereby represents
and warrants that the undersigned is (check whichever applies):

 

	 	☐	an
    employee benefit plan within the meaning of the Employment Retirement Income Security Act of 1974, as amended (“ERISA”),
    if either:

 

	 	a.	the
    investment decision is made by a plan fiduciary, as defined in ERISA § 3(21), that is a bank, savings and loan association,
    insurance company or registered investment adviser,

 

	 	b.	an
    employee benefit plan with total assets in excess of $5,000,000, or

 

	 	c.	a
    self-directed plan with investment decisions made solely by persons who are accredited investors as defined in Rule 501(a)
    promulgated under the Securities Act.

 

	 	☐	one
    of the following entities, not formed for the specific purpose of acquiring securities and having total assets in excess of
    $5,000,000:

 

	 	a.	an
    organization described in Section 501(c)(3) of the Internal Revenue Code of 1986, as amended;

 

	 	b.	a
    corporation, partnership, or limited liability company; or

 

	 	c.	a
    Massachusetts or similar business trust.

 

	 	☐	a
    bank as defined in Section 3(a)(2) of the Securities Act, or any savings and loan association or other institution as defined
    in Section 3(a)(5)(A) of the Securities Act, whether acting in its individual or a fiduciary capacity.

 

     

     

    

 

	 	☐	a
    broker or dealer registered pursuant to Section 15 of the Securities Exchange Act of 1934, as amended.

 

	 	☐	an
    insurance company as defined in Section 2(13) of the Securities Act.

 

	 	☐	an
    investment company registered under the Investment Company Act of 1940 (the “Investment Company Act”),
    or a business development company as defined in Section 2(a)(48) of the Investment Company Act.

 

	 	☐	a
    Small Business Investment Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the Small
    Business Investment Act of 1958.

 

	 	☐	a
    plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its
    political subdivisions for the benefit of its employees with total assets in excess of $5,000,000.

 

	 	☐	a
    private business development company as defined in Section 202(a)(22) of the Investment Advisers Act of 1940, as amended.

 

	 	☐	An
    entity in which all of the equity owners are “accredited investors” under any of the above categories
    (including the categories for individuals and trusts listed in the preceding Sections 1(a) and 1(b)). If the
    undersigned belongs to this investor category only, list the equity owners of the undersigned, and the “accredited investor”
    category which each such equity owner satisfies:
	 	 	 
	 	 	 
	 	 	 

 

 

If
the Issuer needs to verify my status as an accredited investor or has any questions with respect to such status, I hereby consent
to request that the Issuer contact:

 

	Name:	 	 
	 	 	 
	Firm name:	 	 
	 	 	 
	Email:	 	 
	 	 	 
	Telephone:	 	 
	 	 	 
	Address:	 	 

 

	Relationship to accredited investor:	 	 

 

II.
Not an Accredited Investor: The undersigned hereby represents and warrants that the undersigned does NOT meet one of the
foregoing tests and does not qualify as an “accredited investor” under Regulation D promulgated under the Securities
Act. ☐ (please check box if you are not an accredited investor)

 

Signature
Page Follows

 

     

     

    

 

The
undersigned has/have executed this Accredited Investor Questionnaire effective as of the date set forth below.

 

	 	FOR INDIVIDUALS
	 	 	 
	 	By:	 
	 	 	Signature
	 	 	 
	 	Name:	 
	 	 	 
	 	Date:	 
	 	 	 
	 	By:	 
	 	 	Signature
	 	 	 
	 	Name:	 
	 	 	 
	 	Date:	 

 

	NOTE:
                                         IF YOU ARE PURCHASING SHARES WITH YOUR SPOUSE, YOU MUST BOTH SIGN THIS SIGNATURE PAGE.

                                                  

                                                 IF
                                         YOU ARE PURCHASING SHARES WITH ANOTHER PERSON NOT YOUR SPOUSE, YOU MUST EACH FILL OUT
                                         A SEPARATE QUESTIONNAIRE.

 

	 	FOR ENTITIES
	 	 	 
	 	 	 
	 	Name of Entity (i.e., corporation, partnership, trust, LLC etc.)
	 	 	 
	 	By:	 
	 	 	Signature
	 	 	 
	 	Name:	 
	 	 	 
	 	Title:	 
	 	 	 
	 	Date:	 

 

     

     

    

 

EXHIBIT
E

 

Form
of Irrevocable Transfer Agent Instructions

 

     

     

    

 

TRANSFER
AGENT INSTRUCTIONS

 

ENER-CORE,
INC.

 

November
1, 2017

 

VStock
Transfer, LLC

18
Lafayette Place

Woodmere,
New York 11598

Telephone: (212) 828-8436

Facsimile:
(646) 536-3179

Attention:
Yoel Goldfeder

E-mail:
yoel@vstocktransfer.com

 

Ladies
and Gentlemen:

 

Reference
is made to that certain Amended and Restated Securities Purchase Agreement, dated as of November 1, 2017 (as amended, restated,
modified or joined from time to time, the “Agreement”), by and among Ener-Core, Inc., a Delaware corporation
(the “Company”), and the investors named on each Buyer’s signature page to a Joinder Agreement with respect
to the Agreement and the Schedule of Buyers attached hereto (collectively, the “Holders”), pursuant to which
the Company is issuing to the Holders: (i) convertible senior secured promissory notes (the “Notes”), which
Notes shall be convertible into shares of common stock of the Company, par value $0.0001 per share (the “Common Stock”)
and (ii) warrants (the “Warrants”), which are exercisable to purchase shares of Common Stock.

 

This
letter shall serve as our irrevocable authorization and direction to you (provided that you are the transfer agent of the Company
at such time):

 

	 	(i)	to
    issue shares of Common Stock upon conversion of the Notes (the “Conversion Shares”) to or upon the order
    of a Holder from time to time upon delivery to you of a properly completed and duly executed Conversion Notice, in the form
    attached hereto as Exhibit I, which has been acknowledged by the Company as indicated by the signature of a duly authorized
    officer of the Company thereon; and

 

	 	(ii)	to
    issue shares of Common Stock upon exercise of the Warrants (the “Warrant Shares”) to or upon the order
    of a Holder from time to time upon delivery to you of a properly completed and duly executed Exercise Notice, in the form
    attached hereto as Exhibit II, which has been acknowledged by the Company as indicated by the signature of a duly authorized
    officer of the Company thereon.

 

You
acknowledge and agree that so long as you have previously received (a) a written legal opinion from the Company’s legal
counsel that either (i) a registration statement covering resales of the Conversion Shares and/or Warrant Shares has been declared
effective by the Securities and Exchange Commission (“SEC”) under the Securities Act of 1933, as amended (the
“Securities Act”), or (ii) sales of the Conversion Shares and/or the Warrant Shares may be made in conformity
with Rule 144 under the Securities Act (“Rule 144”) and (b) if applicable, a copy of such registration statement,
then within three (3) business days of your receipt of a notice of transfer, Conversion Notice or Exercise Notice, you shall issue
the certificates representing the Conversion Shares and/or the Warrant Shares, as applicable, registered in the names of such
transferees, and such certificates shall not bear any legend restricting transfer of the Conversion Shares and/or the Warrant
Shares thereby and should not be subject to any stop-transfer restriction; provided, however, that if such Conversion Shares
and Warrant Shares are not registered for resale under the Securities Act or able to be sold under Rule 144, then the certificates
for such Conversion Shares and/or Warrant Shares shall bear the following legend:

 

THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE
STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN
EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL,
IN FORM AND SUBSTANCE REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD
PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH
A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

 

[Remainder
of page left blank intentionally. Signatures follow.]

 

     

     

    

 

Please
execute this letter in the space indicated to acknowledge your agreement to act in accordance with these instructions. Should
you have any questions concerning this matter, please contact me at 949-616-3300.

 

	 	Very truly yours,
	 	 
	 	ENER-CORE, INC.
	 	 	 
	 	By:	 
	 	Name:	Domonic J. Carney
	 	Title:	Chief Financial Officer

 

THE
FOREGOING INSTRUCTIONS ARE

ACKNOWLEDGED
AND AGREED TO

 

this
___ day of November, 2017

 

VSTOCK
TRANSFER, LLC

 

	By:	 	 
	Name:	Yoel Goldfeder	 
	Title:	Chief Executive Officer	 

Enclosures

 

Signature
Page to Transfer Agent Instructions

 

     

     

    

 

EXHIBIT
I

 

CONVERSION
NOTICE

 

ENER-CORE,
inc.

 

Reference
is made to the convertible unsecured promissory note (the “Note”) issued to the undersigned by Ener-Core, Inc.,
a Delaware corporation (the “Company”). In accordance with and pursuant to the Note, the undersigned hereby
elects to convert the Conversion Amount (as defined in the Note) of the Note indicated below into shares of Common Stock par value
$0.0001 per share (the “Common Stock”) of the Company, as of the date specified below.

 

 

	 	Date of Conversion:	
	 	

        

        Aggregate Conversion Amount to be converted:
	 
    

 

 

 

Please
confirm the following information:

 

	 	Conversion Price:	 
	 	

        Number of shares of Common Stock to be issued:
	 

 

 

 

Please
issue the Common Stock into which the Note is being converted in the following name and to the following address:

 

 

	Issue to:	 
    
	 
    	 
	 
    	 
	 
    	 
	

        

        Facsimile Number and E-mail Address:
	 
	 
    	 
	 
    	 
	 
    	 
	Authorization:	 
	By:	 
	Title:	 
	Dated:	 

 

	Account Number (if book entry transfer):	 
	

        Transaction Code Number (if book entry transfer):
	 
    
	Installment Amounts to be reduced and amount of reduction:	 

 

Exhibit
I

 

     

     

    

 

ACKNOWLEDGMENT

 

The
Company hereby acknowledges this Conversion Notice and hereby directs VStock Transfer, LLC to issue the above indicated number
of shares of Common Stock in accordance with the Transfer Agent Instructions dated November 1, 2017 from the Company and acknowledged
and agreed to by VStock Transfer, LLC.

 

 

	 	ENER-CORE,
    INC.
	 	 	 
	 	By:	         
	 	Name:	 
	 	Title:	 

 

     

     

    

 

EXHIBIT
II

 

EXERCISE
NOTICE

 

TO
BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS

WARRANT
TO PURCHASE COMMON STOCK

 

ENER-CORE,
inc.

 

The
undersigned holder hereby exercises the right to purchase _________________ of the shares of Common Stock (“Warrant Shares”)
of Ener-Core, Inc., a Delaware corporation (the “Company”), evidenced by the attached Warrant to Purchase Common
Stock (the “Warrant”). Capitalized terms used herein and not otherwise defined shall have the respective meanings
set forth in the Warrant.

 

1. Form
of Exercise Price. The Holder intends that payment of the Exercise Price shall be made as:

 

____________
a “Cash Exercise” with respect to _________________ Warrant Shares; and/or

 

____________
a “Cashless Exercise” with respect to _______________ Warrant Shares.

 

2.
Payment of Exercise Price. In the event that the holder has elected a Cash Exercise with respect to some or all of the
Warrant Shares to be issued pursuant hereto, the holder shall pay the Aggregate Exercise Price in the sum of $___________________
to the Company in accordance with the terms of the Warrant.

 

3.
Delivery of Warrant Shares. The Company shall deliver to the holder __________ Warrant Shares in accordance with the terms
of the Warrant.

 

Date:
_______________ __, ______

 

	 	 	 	 
	Name
    of Registered Holder
	 	 	 	 
	By:	 	 	 
	 	Name:	 	 
	 	Title:	 	 

 

Exhibit
II

 

     

     

    

 

ACKNOWLEDGMENT

 

The
Company hereby acknowledges this Exercise Notice and hereby directs VStock Transfer, LLC to issue the above indicated number of
shares of Common Stock in accordance with the Transfer Agent Instructions dated November 1, 2017 from the Company and acknowledged
and agreed to by VStock Transfer, LLC.

 

	 	ENER-CORE,
    INC.
	 	 	 
	 	By:	         
	 	Name:	 
	 	Title:	 

 

     

     

    

 

SCHEDULE
OF BUYERS

 

	(1)	 	(2)	 	(3)	 	(4)	 	(5)	 	(6)
	Buyer	 	Address and

Facsimile Number	 	Aggregate Principal Amount of Notes	 	Number of

Warrant Shares	 	Purchase Price	 	Legal Representative’s Address and Facsimile Number
	 	 	 	 	 	 	 	 	 	 	 
	TOTAL	 	 	 	$222,222.22	 	177,778	 	$400,000.00	 	 

 

 

Exhibit
II

 

     

     

    

 

EXHIBIT
F

 

Form
of Secretary’s Certificate

 

  

     

     

    

 

 

SECRETARY’S
CERTIFICATE

 

Pursuant
to Section 7(b)(vi) of the Amended and Restated Securities Purchase Agreement, dated as of November 1, 2017 (the “Purchase
Agreement”), by and among Ener-Core, Inc., a Delaware corporation (the “Company”), and the investors
set forth on the Schedule of Buyers attached to the Purchase Agreement and the investors, if any, party to a joinder agreement
with respect to the Purchase Agreement (each, a “Buyer” and collectively, the “Buyers”),
Domonic J. Carney, the Secretary of the Company, hereby certifies, in his capacity as an officer of the Company and as an officer
of Ener-Core Power, Inc., a Delaware corporation (the “Subsidiary”), and not individually, on behalf of the
Company and the Subsidiary, respectively, that:

 

 

		1.	Attached hereto as Exhibit A are true, correct and complete copies of resolutions duly adopted
by the Board of Directors (the “Board”) of the Company and the Board of Directors (the “Subsidiary
Board”) of the Subsidiary (collectively, the “Board Resolutions”), approving the matters contemplated
by Section 3(b) of the Purchase Agreement. Such resolutions have not been amended, modified, supplemented, annulled or revoked
and are in full force and effect in the form adopted, and are the only resolutions adopted by the Board and the Subsidiary Board
or by any committee of or designated by the Board and Subsidiary Board relating to (i) the transactions contemplated by the Board
Resolutions, and (ii) the transaction agreements identified in the Board Resolutions. All members of the Board and Subsidiary Board
were, at the time of their approval of the resolutions attached hereto as Exhibit A, respectively, and have been at all
times thereafter, duly elected, qualified, and acting directors of the Company and the Subsidiary, respectively.

 

		2.	Attached hereto as Exhibit B are true, correct and complete copies of the Certificate of
Incorporation of the Company, as currently in effect (the “Certificate”), and the Certificate of Incorporation
of the Subsidiary, as currently in effect (the “Subsidiary Certificate”). The Certificate has not been amended
subsequent to September 3, 2015, and no action has been taken by the Company, its stockholders, directors, or officers to authorize
or effect any further amendment or modification to such Certificate, and the Subsidiary Certificate has not been amended subsequent
to June 28, 2013, and no action has been taken by the Subsidiary, its stockholders, directors, or officers to authorize or effect
any further amendment or modification to such Subsidiary Certificate.

 

		3.	Attached hereto as Exhibit C are true, correct and complete copies of the Bylaws of the
Company, as currently in effect (the “Bylaws”), and the Bylaws of the Subsidiary, as currently in effect (the
“Subsidiary Bylaws”). The Bylaws have not been amended subsequent to September 3, 2015, and no action has been
taken by the Company, its stockholders, directors, or officers to authorize or effect any further amendment or modification to
such Bylaws, and the Subsidiary Bylaws have not been amended subsequent to August 1, 2012, and no action has been taken by the
Subsidiary, its stockholders, directors, or officers to authorize or effect any further amendment or modification to such Subsidiary
Bylaws.

 

		4.	Each person listed below has been duly elected or appointed to the position(s) indicated opposite
his name and is duly authorized to sign the Purchase Agreement and each of the Transaction Documents on behalf of the Company,
and the signature appearing opposite such person’s name below is such person’s genuine signature.

 

	 	Name	 	Position	 	Signature
	 	Alain J. Castro	 	Chief Executive Officer	 	

 

 

		5.	Each person listed below has been duly elected or appointed to the position(s) indicated opposite
his name and is duly authorized to sign each of the Transaction Documents of which the Subsidiary is a party on behalf of the Subsidiary,
and the signature appearing opposite such person’s name below is such person’s genuine signature.

 

	 	Name	 	Position	 	Signature
	 	Alain J. Castro	 	Chief Executive Officer	 	

 

Capitalized
terms contained herein and not otherwise defined shall be interpreted in accordance with their meaning in the Purchase Agreement.

 

[Signature
Page Follows]

 

     

     

    

 

IN
WITNESS WHEREOF, the undersigned has signed his name to this Secretary’s Certificate this November 1, 2017.

 

	 	By: 	 
	 	Name: 	Domonic J. Carney
	 	Title: 	Secretary

 

 

I,
Alain Castro, Chief Executive Officer, hereby certify that Domonic J. Carney is the duly elected, qualified and acting Secretary
of the Company and that the signature set forth above is his true signature.

 

	 	By: 	 
	 	Name: 	Alain Castro
	 	Title: 	Chief Executive Officer

 

Signature
Page to Secretary’s Certificate

 

     

     

    

 

EXHIBIT
A

 

Board
Resolutions

 

     

     

    

 

Subsidiary
Board Resolutions

 

 

     

     

    

 

EXHIBIT
B

 

Certificates
of Incorporation

 

     

     

    

 

EXHIBIT
C

 

Bylaws

 

     

     

    

 

EXHIBIT
G

 

Form
of Officer’s Certificate

 

     

     

    

 

COMPLIANCE
CERTIFICATE

 

Pursuant
to Section 7(b)(vii) of the Amended and Restated Securities Purchase Agreement, dated as of November 1, 2017 (the “Purchase
Agreement”), by and among Ener-Core, Inc., a Delaware corporation (the “Company”), and the investors
set forth on the Schedule of Buyers attached to the Purchase Agreement and the investors, if any, party to a joinder agreement
with respect to the Purchase Agreement (each, a “Buyer” and collectively, the “Buyers”),
Alain J. Castro, the Chief Executive Officer of the Company, hereby certifies, in his capacity as an officer of the Company and
not individually, on behalf of the Company and to the best of his knowledge after a reasonable investigation that:

 

1.
The representations and warranties of the Company contained in Section 3 of the Purchase Agreement are true and correct in all
material respects (except for those representations and warranties that are qualified by materiality or Material Adverse Effect,
which shall be true and correct in all respects) as of the date when made and as of the Closing Date as though made at that time
(except for representations and warranties that speak as of a specific date which shall be true and correct as of such specified
date).

 

2.
The Company has performed, satisfied and complied in all respects with the covenants, agreements and conditions required by the
Transaction Documents to be performed, satisfied or complied with by the Company at or prior to the Closing Date.

 

Capitalized
terms contained herein and not otherwise defined shall be interpreted in accordance with their meaning in the Purchase Agreement.

 

[Signature
Page Follows]

 

     

     

    

 

IN
WITNESS WHEREOF, the undersigned has signed his name to this Compliance Certificate this November 1, 2017.

 

	 	By: 	 
	 	Name: 	Alain J. Castro
	 	Title: 	Chief Executive Officer

 

Signature
Page to Compliance Certificate 

 

     

     

    

 

DISCLOSURE SCHEDULES TO SECURITIES PURCHASE
AGREEMENT

 

(Note: Capitalized terms used herein
and not otherwise defined shall have the definitions ascribed to such terms in the Agreement.)

 

Schedule 3(a)

(Subsidiaries)

 

Ener-Core Power, Inc., a Delaware corporation

 

Schedule 3(j)

(SEC Documents; Financial Statements)

 

None.

 

Schedule 3(m)

(Regulatory Permits)

 

None.

 

Schedule 3(o)

(Sarbanes-Oxley Act)

 

None, other than as disclosed in the Company’s
Annual Report on Form 10-K for the year ended December 31, 2016, as updated by the Company’s Quarterly Reports on Form 10-Q
for the quarterly periods ended March 31, 2017 and June 30, 2017, and as described in Schedule 3(bb) below.

 

Schedule 3(p)

(Transactions with Affiliates)

 

None.

 

Schedule 3(q)

(Equity Capitalization)

 

		(ii)	Outstanding options, warrants, scrip, rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities or rights convertible into, or exercisable or exchangeable for, any shares of capital stock
of the Company or any of its Subsidiaries, or contracts, commitments, understandings or arrangements by which the Company or any
of its Subsidiaries is or may become bound to issue additional shares of capital stock of the Company or any of its Subsidiaries
or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities
or rights convertible into, or exercisable or exchangeable for, any shares of capital stock of the Company or any of its Subsidiaries.

 

None.

 

     

     

    

 

		(iii)	Outstanding debt securities, notes, credit agreements, credit facilities or other agreements,
documents or instruments evidencing Indebtedness of the Company or any of its Subsidiaries or by which the Company or any of its
Subsidiaries is or may become bound.

 

None.

 

		(iv)	Financing statements securing obligations in any material amounts, either singly or in the aggregate,
filed in connection with the Company or any of its Subsidiaries.

 

UCC financing statements have been
filed in connection with (i) the issuance by the Company of the 2015 Senior Notes (as defined below), (ii) the CLA (as defined
below) (iii) certain of its capital lease obligations.

 

		(v)	Agreements or arrangements under which the Company or any of its Subsidiaries is obligated to
register the sale of any of their securities under the 1933 Act.

 

In connection with the issuance
and sale of the 2016 Senior Notes (as defined hereinafter), the Company entered into a Registration Rights Agreement with the investors
(the “Registration Rights Agreement”), pursuant to which the Company is required to file one or more registration
statements with the Securities and Exchange Commission (the “SEC”) to register for resale by the investors the
shares issuable upon conversion of the 2016 Senior Notes (the “Conversion Shares”) and shares underlying certain
warrants issued to the holders of the 2016 Senior Notes (the “Warrant Shares”), and use its best efforts to
maintain the effectiveness of such registration statement(s). The Company was required to file the first such registration statement
promptly following the initial closing date under the securities purchase agreement for the 2016 Senior Notes, which occurred on
December 2, 2016, but in no event later than the date that is forty-five (45) days after such initial closing date. The Registration
Rights Agreement required the Company to obtain effectiveness of the required registration statement by specified deadlines contained
in the Registration Rights Agreement. The Company complied with its obligation to file such registration statement on January 17,
2017 and the SEC declared such registration statement effective on February 21, 2017. In connection with the execution of the execution
of the Transaction Documents, the required number of investors has waived the Company’s ongoing maintenance obligations pursuant
to the Registration Rights Agreement with respect to such Conversion Shares and Warrant Shares.

 

Liabilities or obligations
required to be disclosed in the SEC Documents but not so disclosed in the SEC Documents, other than those incurred in the ordinary
course of the Company’s or any of its Subsidiary’s’ respective businesses and which, individually or in the aggregate,
do not or would not have a Material Adverse Effect

 

None.

 

     

     

    

 

Schedule 3(r)

(Indebtedness and Other Contracts)

 

Convertible Unsecured Notes (as defined below) payable consisted
of the following as of June 30, 2017:

 

	 	 	Notes	 	 	Debt
 Discount
	 	 	Offering Costs	 	 	Net
 Total
	 
	December 31, 2016 Balance	 	$	1,250,000	 	 	$	(666,000	)	 	$	(30,000	)	 	$	554,000	 
	Amortization of debt discount and deferred financing costs	 	 	—	 	 	 	552,000	 	 	 	22,000	 	 	 	574,000	 
	Issuance of additional warrants	 	 	 	 	 	 	(73,000	)	 	 	—	 	 	 	(73,000	)
	Ending balance—June 30, 2017	 	 	1,250,000	 	 	 	(187,000	)	 	 	(8,000	)	 	 	1,055,000	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Less: Current Portion	 	$	(1,250,000	)	 	$	187,000	 	 	$	8,000	 	 	$	(1,055,000	)
	Long Term Portion	 	$	—	 	 	$	—	 	 	$	—	 	 	$	—	 

 

On September 1, 2016, the Company entered
into a securities purchase agreement and related notes and warrants pursuant to which it issued certain convertible unsecured promissory
notes (the “Convertible Unsecured Notes”) and detachable five-year warrants to purchase an aggregate of 124,999
shares of the Company’s common stock at an exercise price of $4.00 per share (the “September 2016 Financing”).
The Company received total gross proceeds of $1,250,000, less transaction expenses of $45,000 consisting of legal costs for net
proceeds of $1,205,000.

 

The Convertible Unsecured Notes bear interest
at a rate of 12% per annum and mature on September 1, 2017; provided, however, that the Company may not prepay any portion of the
outstanding principal and accrued and unpaid interest under the Convertible Unsecured Notes so long as any of the Senior Notes
(as defined hereinafter) remain outstanding and in no event will the maturity date of such Convertible Unsecured Notes be earlier
than at least ninety-one (91) days after the maturity date under the Senior Notes. The Convertible Unsecured Notes are subordinate
to the Senior Notes. The Convertible Unsecured Notes were initially convertible at the option of the holder into common stock at
a conversion price of $4.31 per share and will automatically convert into shares of common stock in the event of a conversion of
at least 50% of the then outstanding (i) principal, (ii) accrued and unpaid interest with respect to such principal and (iii) accrued
and unpaid late charges, if any, with respect to such principal and interest, under the Senior Notes. In connection with the issuance
of the 2016 Senior Notes (as defined hereinafter) and amendment and restatement of the 2015 Senior Notes (as defined hereinafter),
the conversion price was reduced to $2.50 per share. The Convertible Unsecured Notes also contain a blocker provision that prevents
the Company from effecting a conversion in the event that the holder, together with certain affiliated parties, would beneficially
own in excess of 9.99% of the shares of common stock outstanding immediately after giving effect to such conversion. At any time
after the issuance date of the Convertible Unsecured Notes, the Company may, at its option, redeem all or any portion of the then
outstanding principal and accrued and unpaid interest with respect to such principal (the “Company Optional Redemption
Amount”), at 100% of such aggregate amount; provided, however, that the Company may not redeem all or any portion of
the Company Optional Redemption Amount so long as any of the Senior Notes remain outstanding without the prior written consent
of the collateral agent with respect to such Senior Notes and certain investors holding the requisite number of conversion shares
and warrant shares underlying the Senior Notes and certain related warrants.

 

The securities purchase agreement for the
Convertible Unsecured Notes called for the issuance of additional five-year warrants to purchase an aggregate of 62,500 shares
at an exercise price of $4.00 per share on each of the 61st, 91st, 121st and 151st days after the closing of the September 2016
Financing (in each case, an “Additional Warrant Date”), but only in the event the Company had not consummated
a further financing consisting of the issuance of common stock and warrants for aggregate gross proceeds of at least $3,000,000
prior to such respective Additional Warrant Date. As of January 30, 2017, the Company had not consummated a further financing and,
as a result, issued warrants to purchase an aggregate of 250,000 shares of the Company’s common stock, consisting of the
issuance of an aggregate of 62,500 shares of the Company’s common stock on each of November 1, 2016, December 1, 2016, December
31, 2016 and January 30, 2017.

 

     

     

    

 

The terms of the Convertible Unsecured
Notes and the related warrants, including the related agreements, are also described in the Company’s Current Report on Form
8-K, filed September 2, 2016 (EDGAR Link), incorporated by reference herein.

 

Leases Payable 

 

Capital leases payable consisted of the
following:

 

	 	 	June
30,

2017
 (unaudited)
	 	 	December 31,
 2016	 
	 	 	 	 	 	 	 
	Capital lease payable to De Lange Landon secured by forklift, 10.0% interest, due on October 1, 2018, monthly payment of $452.	 	$	7,000	 	 	$	10,000	 
	Capital lease payable to Dell Computers secured by computer equipment, 15.09% interest, due on November 22, 2017, monthly payment of $394.	 	 	2,000	 	 	 	4,000	 
	Capital lease payable to Dell Computers secured by computer equipment, 4.99% interest, due on May 1, 2020, monthly payment of $716.	 	 	24,000	 	 	 	—	 
	Total capital leases	 	$	33,000	 	 	$	14,000	 
	Less: current portion	 	 	(15,000	)	 	 	(10,000	)
	Long-term portion of capital leases	 	$	18,000	 	 	$	4,000	 

 

Standby Letter of Credit 

 

Pursuant to the terms of the Commercial
License Agreement (“CLA”), dated as of November 14, 2014, by and between the Company and Dresser-Rand, the Company
is required to provide a backstop security of $2.1 million to secure performance of certain obligations under the CLA (the “Backstop
Security”). Effective November 2, 2015, the Company executed that certain Backstop Security Support Agreement (the “Support
Agreement”), pursuant to which an investor agreed to provide the Company with financial and other assistance (including
the provision of sufficient and adequate collateral) as necessary in order for the Company to obtain a $2.1 million letter of credit
acceptable to Dresser-Rand as the Backstop Security and with an expiration date of June 30, 2017 (“Letter of Credit”).
If the investor is required to make any payments on the Letter of Credit, subject to the terms of the Intercreditor Agreement (as
defined hereinafter), the Company must reimburse the investor the full amount of any such payment. Such payment obligation is secured
by a pledge of certain collateral of the Company pursuant to a Security Agreement dated November 2, 2015 (“Security Agreement”),
and the security interest in favor of and the payment obligations to the investor are subject to the terms of that certain Subordination
and Intercreditor Agreement executed concurrently with the Support Agreement and Security Agreement (the “Intercreditor
Agreement”) by and among the investor, the Company and the collateral agent pursuant to the Senior Notes.

 

The term of the Company’s obligations
under the Support Agreement (the “Term”) commenced on November 2, 2015, the issuance date of the Letter of Credit,
and will terminate on the earliest of: (a) replacement of the Letter of Credit with an alternative Backstop Security in favor
of Dresser-Rand, (b) Dresser-Rand eliminating the Backstop Security requirement under the CLA, or (c) the last day of the
twenty-fourth calendar month following the commencement of the Term. In consideration of the investor’s support commitment,
the Company paid the investor a one-time fee equal to 4% of the amount of the Letter of Credit and is obligated to pay a monthly
fee equal to 1% of the amount of the Letter of Credit for the first twelve months. If the Support Agreement has not terminated
after the initial twelve months, the Company will pay another one-time fee equal to 4% of the amount of the Letter of Credit, and
a monthly fee equal to 2% of the amount of the Letter of Credit for up to another twelve months.

 

     

     

    

 

Amendments to Backstop Security and
Senior Notes

 

In June 2016, the Company executed a contract
manufacturing and commercial licensing agreement (the “CMLA”) with Dresser-Rand, which both companies intended
would supersede and replace the CLA. In April 2017, the Company amended the terms of the CMLA to make the CMLA effective as of
January 1, 2017, at which time it superseded and replaced the CLA. Further, effective as of April 27, 2017, the Company executed
a First Amendment to the Support Agreement (the “BSSA Amendment”), with the individual investor. The BSSA Amendment
is intended to conform the terms of the Support Agreement and related Letter of Credit to the terms of the CMLA. The BSSA Amendment
(i) reduces the security obligation underlying the Letter of Credit from $2.1 million to $500,000, consistent with the current
terms of the CMLA, (ii) extends the term of the backstop security to March 31, 2018, (iii) reduces the related fee payable under
the Support Agreement to 1% per month for the remainder of the term, (iv) provided for the amendment and restatement of the warrant
issued to the investor in connection with the execution of the Support Agreement in order to reduce the exercise price per share
of common stock of to $3.00 and insert a beneficial ownership blocker provision at 4.99% and (v) provided that the Company would
issue the investor an additional warrant to purchase 41,000 shares of Common Stock at an exercise price of $3.00 per share, subject
to a 4.99% beneficial ownership blocker.

 

In connection with the execution of the
BSSA Amendment, on April 27, 2017, the Company and certain investors holding Senior Notes executed first amendments to such Senior
Notes to revise the definition of “Backstop Agreement” to include any amendments, restatements, supplements
or other modifications thereof, as may be permitted thereunder.

 

For detailed terms of the Backstop Security
and related documents, see the Company’s Current Reports on Form 8-K filed November 3, 2015 (EDGAR Link) and May 1,
2017 (EDGAR Link), each incorporated by reference herein.

 

Capital Leases

 

The Company leases certain assets, primarily
computer equipment under agreements expiring in 2020. The total amount of the capital leases is approximately $35,000.

 

Operating Leases

 

The Company leases its office facility,
research and development facility and equipment under operating leases, which for the most part, are renewable. The leases also
provide that the Company will pay insurance and taxes. The Company’s primary operating lease expired on December 31, 2016
and it extended the lease for a three-month period ending March 31, 2017 at a reduced interim rate. The Company signed a new lease
in February 2017 for a separate facility and moved into the new headquarters facilities in April 2017.

 

Through March 31, 2017, the Company’s
headquarters was located at 9400 Toledo Way, Irvine, California 92618.  The property consisted of a mixed use commercial
office, production, and warehouse facility of 32,649 square feet and expired December 31, 2016. The Company extended the lease
at a reduced rate until March 31, 2017.  The monthly rent was $15,000 per month for the three months ended March 31,
2017. As of April 1, 2017, the Company’s headquarters is located at 8965 Research Drive, Suite 100, Irvine, California 92618
and consists of a mixed use commercial office of 4,960 square feet. From January through March 2017, the Company’s monthly
rent was $15,000 for the Toledo Way property holdover and, from April 1, 2017, its monthly rent is $10,168 per month, with annual
escalations on April 1, 2018 to $10,473 per month and on April 1, 2019 to $10,787 per month for the Research Drive property. The
Toledo Way lease terminated on April 1, 2017 and the Research Drive property lease expires on March 31, 2020.

 

     

     

    

 

Senior Secured Notes

 

Convertible Senior Notes payable consisted of the following
as of June 30, 2017:

 

	 	 	Principal	 	 	Debt
 Discount
	 	 	Offering Costs	 	 	Net
 Total
	 
	Balance, December 31, 2016	 	$	9,191,000	 	 	$	(8,152,000	)	 	$	(409,000	)	 	$	630,000	 
	Amortization of Debt Discount and Offering Costs	 	 	—	 	 	 	2,029,000	 	 	 	102,000	 	 	 	2,131,000	 
	Conversion into common shares	 	 	(60,000	)	 	 	50,000	 	 	 	3,000	 	 	 	(7,000	)
	Balance, June 30, 2017	 	 	9,131,000	 	 	 	(6,073,000	)	 	 	(304,000	)	 	 	2,754,000	 
	Less: Current Portion	 	 	—	 	 	 	—	 	 	 	—	 	 	 	—	 
	Long Term Portion	 	$	9,131,000	 	 	$	(6,073,000	)	 	$	(304,000	)	 	$	2,754,000	 

 

In the fourth quarter of 2016, the Company
entered into a securities purchase agreement pursuant to which it issued a new series of convertible senior secured notes (collectively,
the “2016 Senior Notes”) and related warrants, and entered into amendment agreements related to the convertible
senior secured notes originally issued in April and May 2015 (the “2015 Senior Notes”) and the Convertible Unsecured
Notes. The Company issued and sold new 2016 Senior Notes with a face value of $3,747,000 and an original issue discount of $375,000
for gross cash proceeds of $3,372,000. Additionally, the Company amended and restated the 2015 Senior Notes, the aggregate principal
amount of which was $5,000,000 prior to such amendment and restatement. Upon the amendment and restatement of the 2015 Senior Notes,
the face value of such 2015 Senior Notes was $5,556,000 with an original issue discount of $556,000. The Company refers to the
2016 Senior Notes and the amended and restated 2015 Senior Notes, collectively, as the “Senior Notes”. The Senior
Notes are fully secured by all assets of the Company and the Company’s subsidiaries. The Senior Notes are convertible at
a price per share of $2.50, which is adjustable upon a Company stock split, reverse split, or common share dividend. In conjunction
with the issuance and/or amendment and restatement, as applicable, of the aggregate face value of $9,302,000 of the Senior Notes,
the Company issued five-year warrants to purchase up to 3,720,839 shares of the Company’s common stock at $3.00 per share.
The Company incurred $479,000 of offering costs in conjunction with the issuance and sale of the 2016 Senior Notes and amendment
and restatement of the 2015 Senior Notes, consisting of $298,000 of placement agent fees and costs and $181,000 of legal and professional
fees.

 

Upon an Event of Default, the Senior Notes
will bear interest at a rate of 10% per annum. The Senior Notes will mature on December 31, 2018 and rank senior to the Convertible
Unsecured Notes. The Senior Notes are convertible at the option of the holder into the Company’s common stock at an exercise
price of $2.50 (as subject to adjustment therein) and will automatically convert into shares of the Company’s common stock
on the fifth trading day immediately following the issuance date of the Senior Notes on which (i) the Weighted Average Price (as
defined in the Senior Notes) of the Company’s common stock for each trading day during a twenty trading day period equals
or exceeds $5.00 (as adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction)
and no Equity Conditions Failure (as defined in the Senior Notes) has occurred. The Senior Notes also contain a blocker provision
that prevents the Company from effecting a conversion in the event that the holder, together with certain affiliated parties, would
beneficially own in excess of either 4.99% or 9.99%, with such threshold determined by the holder prior to issuance, of the shares
of the Company’s common stock outstanding immediately after giving effect to such conversion.

 

     

     

    

 

Upon an Event of Default and delivery to
the holder of the Senior Note of notice thereof, such holder may require the Company to redeem all or any portion of its Senior
Note at a price equal to 115% of the Conversion Amount (as defined in the Senior Notes) being redeemed. Additionally, upon a Change
of Control and delivery to the holder of the Senior Note of notice thereof, such holder may also require the Company to redeem
all or any portion of its Senior Note at a price equal to 115% of the Conversion Amount being redeemed. Further, at any time from
and after January 1, 2018 and provided that the Company has not received either (i) initial deposits for at least eight 2 MW Power
Oxidizer units or (ii) firm purchase orders totaling not less than $3,500,000 and initial payment collections of at least $1,600,000,
in each case during the period commencing on the issuance date of the 2016 Senior Notes and ending on December 31, 2017, the holder
of the Senior Note may require the Company to redeem all or any portion of its Senior Note at a price equal to 100% of the Conversion
Amount being redeemed.

 

At any time after the issuance date of
the Senior Notes, the Company may redeem all or any portion of the then outstanding principal and accrued and unpaid interest with
respect to such principal, at 100% of such aggregate amount; provided, however, that the aggregate Conversion Amount to be redeemed
pursuant to all Senior Notes must be at least $500,000, or such lesser amount as is then outstanding. The portion of the Senior
Note(s) to be redeemed shall be redeemed at a price equal to the greater of (i) 110% of the Conversion Amount of the Senior Note
being redeemed and (ii) the product of (A) the Conversion Amount being redeemed and (B) the quotient determined by dividing (I)
the greatest Weighted Average Price (as defined in the Senior Notes) of the shares of the Company’s common stock during the
period beginning on the date immediately preceding the date of the notice of such redemption by the Company and ending on the date
on which the redemption by the Company occurs by (II) the lowest Conversion Price (as defined in the Senior Notes) in effect during
such period.

 

The Senior Notes contain a provision that
prevents the Company from entering into or becoming party to a Fundamental Transaction (as defined in the Senior Notes) unless
the Company’s successor entity assumes all of the Company’s obligations under the Senior Notes and the related transaction
documents pursuant to written agreements in form and substance satisfactory to at least a certain number of holders of the Senior
Notes.

 

In connection with foregoing, Ener-Core
Power, Inc., the Company’s wholly-owned subsidiary, entered into a Guaranty, pursuant to which it agreed to guarantee all
of the obligations of the Company under the securities purchase agreement for the 2016 Senior Notes, the Senior Notes and the related
transaction documents.

 

During the six months ended June 30, 2017,
two holders of Senior Notes converted $60,000 of principal into 24,000 shares of the Company’s common stock.

 

Additionally, on September 19, 2017, pursuant
to the Securities Purchase Agreement, the Company issued certain Notes and Warrants, and entered into amendment agreement and waivers
related to the 2015 Senior Notes, 2016 Senior Notes and Convertible Unsecured Notes. The Company issued and sold Notes with an
aggregate face value of $555,555.57 and an original issue discount of $55,555.57 for gross cash proceeds of $500,000. The Notes
rank pari passu with the 2015 Senior Notes and 2016 Senior Notes; provided that the Notes include a provision that provides
for conversion upon a next equity financing.

 

     

     

    

 

The terms of the Senior Notes, as amended
and/or restated to date, including the related securities purchase agreements, and the related pledge, guaranty and intercreditor
agreements, are described in the following Current Reports on Form 8-K, incorporated by reference
herein:

 

		●	Filed
                                         April 23, 2015 (EDGAR
                                         Link)
		●	Filed
                                         May 7, 2015 (EDGAR
                                         Link)
		●	Filed
                                         October 23, 2015 (EDGAR
                                         Link)
		●	Filed
                                         November 3, 2015 (EDGAR
                                         Link)
		●	Filed
                                         November 25, 2015 (EDGAR
                                         Link)
		●	Filed
                                         December 11, 2015 (EDGAR Link)
		●	Filed
                                         December 31, 2015 (EDGAR
                                         Link)
		●	Filed
                                         April 5, 2016 (EDGAR
                                         Link)
		●	Filed
                                         September 2, 2016 (EDGAR
                                         Link)
		●	Filed
                                         October 24, 2016 (EDGAR
                                         Link)
		●	Filed
                                         November 25, 2016 (EDGAR
                                         Link)
		●	Filed
                                         December 2, 2016 (EDGAR
                                         Link)
		●	Filed
                                         December 14, 2016 (EDGAR
                                         Link)
		●	Filed
                                         May 1, 2017 (EDGAR
                                         Link)
		●	Filed
                                         September 20, 2017 (EDGAR
                                         Link)

 

The
Company has approximately $1,800,000 in trade accounts payable as of September 30, 2017.

 

Schedule 3(s)

(Litigation)

 

On September 23, 2016 AMTRA ENGINEERING
B.V. filed a civil lawsuit (Case number 30-2016-00877078-CU-BC-CJC) in the Superior Court, County of Orange, State of California
against Ener-Core Power, Inc. alleging breach of contract and breach of warranty. The lawsuit is due to a billing dispute surrounding
a contractor for the Attero 250Kw unit delivered in June 2014 to the Netherlands. The Company has settled the lawsuit for $42,500
in cash, of which $32,500 remains payable and is expected to be paid after the close of a larger financing. The Company intends
to file a counter-claim against the contractor’s related company to recover $78,000 in unpaid billings.

 

On March 22, 2017, Dian Griesel filed a
civil lawsuit (Case number 30-2017-009001490CU-BC-CJC) in the Superior Court, County of Orange, State of California against Ener-Core
Power, Inc. for 42,657.40 of past due payables for investor relations services performed for the Company during the 2016 fiscal
year. The Company is seeking a potential settlement during the fourth quarter of 2017.

 

A commercial partner of the Company has
notified the Company that such partner may make a claim with respect to an incident involving the Company’s technology; as
of the date of the Agreement, no claim has been received and the Company is unable to quantify the scope of any potential claim.

 

Schedule 3(bb)

(Internal Accounting and Disclosure
Controls)

 

As of December 31, 2016, as updated on
June 30, 2017 the Company’s management, under the supervision and with the participation of its Chief Executive Officer and
Chief Financial Officer, performed an evaluation of the effectiveness of its disclosure controls and procedures (as defined in
Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended).

 

     

     

    

 

Based on such evaluation, the disclosure
controls and procedures of the Company and the Subsidiary as of December 31, 2016 were ineffective at the reasonable assurance
level due to the following material weaknesses in internal control over financial reporting:

 

		1.	The Company does not have full and complete written documentation of its internal control policies
and procedures, primarily for controls related to its inventory procurement and management. Management evaluated the impact of
the Company’s failure to have written documentation of its internal controls and procedures on its assessment of the Company’s
disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness.

 

		2.	The Company does not have sufficient segregation of duties within accounting functions, which is
a basic internal control. Due to its size and nature, segregation of all conflicting duties may not always be possible and may
not be economically feasible. However, to the extent possible, the initiation of transactions, the custody of assets and the recording
of transactions should be performed by separate individuals. Management evaluated the impact of the Company’s failure to
have segregation of duties on its assessment of its disclosure controls and procedures and has concluded that the control deficiency
that resulted represented a material weakness.

  

		3.	For the year ending December 31, 2016, management concluded that the Company’s management
information systems and information technology internal control design was deficient because the potential for unauthorized access
to certain information systems and software applications existed during 2015 in several departments, including corporate accounting.
Additionally, certain key controls for maintaining the overall integrity of systems and data processing were not properly designed
and operating effectively. These deficiencies increased the likelihood of potential material errors in the Company’s financial
reporting. Management evaluated the impact of the Company’s failure to have adequate information technology controls, on
the Company’s assessment of its disclosure controls and procedures and has concluded that the control deficiency that resulted
represented a material weakness.

 

The Company is attempting to remediate
the material weaknesses in its disclosure controls and procedures and internal controls over financial reporting identified in
its Annual Report on Form 10-K for the fiscal year ended December 31, 2016 by refining its internal procedures (see below).  During
the six months ended June 30, 2017, the Company initiated the following corrective actions, which management believes are reasonably
likely to materially affect the Company’s financial reporting, as they are designed to remediate the material weaknesses
as described above:

 

	 	●	The Company has begun the process of further documenting its internal control structure.

 

	 	●	The Company is in the process of further enhancing the supervisory procedures to include additional levels of analysis and quality control reviews within the accounting and financial reporting functions.  The Company has implemented additional anti-fraud measures over its cash disbursements systems.

  

	 	●	It is developing and implementing inventory control procedures.

 

The Company does not expect to have fully
remediated these material weaknesses until management has tested those internal controls and found them to have been remediated.  The
Company expects to complete this process during its annual testing for the fiscal year ending December 31, 2017.

 

     

     

    

 

Schedule 3(dd)

(Ranking of Notes)

 

The Senior Notes and the Notes issued and
issuable pursuant to the Securities Purchase Agreement will rank pari passu. The rights granted pursuant to the Backstop
Agreement are subject to a subordination and intercreditor agreement, and the Convertible Unsecured Notes are subordinated to all
such senior obligations pursuant to another subordination and intercreditor agreement. See also Schedule 3(r).

 

Schedule 3(nn)

(No Disagreements with Accountants and
Lawyers)

 

The Company owes certain outstanding balances
with respect to fees incurred by its accountants and lawyers; however, the Company does not anticipate that such outstanding fees
owed will affect the Company’s ability to perform any of its obligations under any of the Transaction Documents.

 

Schedule 3(oo)

(No Disqualification Events)

 

None.

 

Schedule 4(s)

(Pledges of Intellectual Property Rights)

 

None, except as provided in the CMLA, as
amended to date.Ex_10_2

		
			Exhibit 10.2
		

		
			INDENMINFICATION AGREEMENT

		

		
			This Indemnification Agreement (“Agreement”) is made as of November 1, 2017 by and between Solaris Oilfield Infrastructure, Inc., a Delaware corporation (the “Company”), and Christopher M. Powell (“Indemnitee”).
		

		
			RECITALS:
		

		
			WHEREAS, directors, officers and other persons in service to corporations or business enterprises are subjected to expensive and time-consuming litigation relating to, among other things, matters that traditionally would have been brought only against the Company or business enterprise itself;
		

		
			WHEREAS, highly competent persons have become more reluctant to serve as directors, officers or in other capacities unless they are provided with adequate protection through insurance and adequate indemnification against inordinate risks of claims and actions against them arising out of their service to and activities on behalf of the corporation;
		

		
			WHEREAS, the Board of Directors of the Company (the “Board”) has determined that the increased difficulty in attracting and retaining such persons is detrimental to the best interests of the Company and its stockholders and that the Company should act to assure such persons that there will be increased certainty of such protection in the future;
		

		
			WHEREAS, (i) the Amended and Restated Bylaws of the Company (as may be amended, the “Bylaws”) requires indemnification of the officers and directors of the Company (ii) Indemnitee may also be entitled to indemnification pursuant to the General Corporation Law of the State of Delaware (“DGCL”) and (iii) the Bylaws and the DGCL expressly provide that the indemnification provisions set forth therein are not exclusive and thereby contemplate that contracts may be entered into between the Company and members of the Board, officers and other persons with respect to indemnification;
		

		
			WHEREAS, this Agreement is a supplement to and in furtherance of the Bylaws and the Amended and Restated Certificate of Incorporation of the Company (as may be amended, the “Certificate of Incorporation”) and any resolutions adopted pursuant thereto, and shall not be deemed a substitute therefore, nor to diminish or abrogate any rights of Indemnitee thereunder; and
		

		
			WHEREAS, (i) Indemnitee does not regard the protection available under the Bylaws and insurance as adequate in the present circumstances, (ii) Indemnitee may not be willing to serve or continue to serve as a director or officer of the Company without adequate protection, (iii) the Company desires Indemnitee to serve in such capacity, and (iv) Indemnitee is willing to serve, continue to serve and to take on additional service for or on behalf of the Company on the condition that Indemnitee be so indemnified.
		

		
			AGREEMENT:
		

		
			NOW, THEREFORE, in consideration of the premises and the covenants contained herein, the Company and Indemnitee do hereby covenant and agree as follows:
		

		
			1.Definitions. 
		

		
			(a) As used in this Agreement:
		

		
			“Corporate Status” describes the status of a person who is or was a director, officer, employee or agent of (i) the Company or (ii) any other corporation, limited liability company, partnership or joint venture, trust, employee benefit plan or other enterprise which such person is or was serving at the request of the Company. 
		

		
			

		 

 

		

		
			“Disinterested Director” shall mean a director of the Company who is not and was not a party to the Proceeding in respect of which indemnification is sought by Indemnitee.
		

		
			“Enterprise” shall mean the Company and any other corporation, limited liability company, partnership, joint venture, trust, employee benefit plan or other enterprise of which Indemnitee is or was serving at the request of the Company as a director, officer, employee, trustee, agent or fiduciary.
		

		
			“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended.
		

		
			“Expenses” shall mean all reasonable costs, expenses, fees and charges, including, without limitation, attorneys’ fees, document and e-discovery costs, litigation expenses, retainers, court costs, transcript costs, fees of experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, and all other disbursements or expenses of the types customarily incurred in connection with prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a witness in, or otherwise participating in, a Proceeding. Expenses also shall include, without limitation, (i) expenses incurred in connection with any appeal resulting from, incurred by Indemnitee in connection with, arising out of, or in respect of or relating to, any Proceeding, including, without limitation, the premium, security for, and other costs relating to any cost bond, supersedes bond, or other appeal bond or its equivalent, (ii) for purposes of Section 12(d) hereof only, expenses incurred by Indemnitee in connection with the interpretation, enforcement or defense of Indemnitee’s rights under this Agreement, by litigation or otherwise, (iii) any federal, state, local or foreign taxes imposed on Indemnitee as a result of the actual or deemed receipt of any payments under this Agreement, and (iv) any interest, assessments or other charges in respect of the foregoing. “Expenses” shall not include “Liabilities.”
		

		
			“Indemnity Obligations” shall mean all obligations of the Company to Indemnitee under this Agreement, including the Company’s obligations to provide indemnification to Indemnitee and advance Expenses to Indemnitee under this Agreement.
		

		
			“Independent Counsel” shall mean a law firm of fifty (50) or more attorneys, or a member of a law firm of fifty (50) or more attorneys, that is experienced in matters of corporation law and neither presently is, nor in the past five (5) years has been, retained to represent: (i) the Company or Indemnitee in any matter material to either such party (other than with respect to matters concerning Indemnitee under this Agreement, or of other indemnitees under similar indemnification agreements), or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder; provided, however, that the term “Independent Counsel” shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee’s rights under this Agreement.
		

		
			“Liabilities” shall mean all claims, liabilities, damages, losses, judgments, orders, fines, penalties and other amounts payable in connection with, arising out of, or in respect of or relating to any Proceeding, including, without limitation, amounts paid in settlement in any Proceeding and all costs and expenses in complying with any judgment, order or decree issued or entered in connection with any Proceeding or any settlement agreement, stipulation or consent decree entered into or issued in settlement of any Proceeding.
		

		
			“Person” shall mean any individual, corporation, partnership, limited partnership, limited liability company, trust, governmental agency or body or any other legal entity.
		

		
			“Proceeding” shall mean any threatened, pending or completed action, claim, suit, arbitration, alternate dispute resolution mechanism, formal or informal hearing, inquiry or investigation, litigation, inquiry, administrative hearing or any other actual, threatened or completed judicial, administrative or arbitration proceeding (including, without limitation, any such proceeding under the Securities Act of 1933, as amended, or the Exchange Act or any other federal law, state law, statute or regulation), whether brought in the right of the Company or otherwise, and whether of a civil, criminal, administrative or investigative nature, in each case, in which Indemnitee was, is or will be, or is threatened to be, involved as a party, witness or otherwise by reason of the fact that Indemnitee is or was a director or officer of 

		 

 

the Company, by reason of any actual or alleged action taken by Indemnitee (or a failure to take action by Indemnitee) or of any action (or inaction) on Indemnitee’s part while acting as director or officer of the Company, or by reason of the fact that Indemnitee is or was serving at the request of the Company as a director, officer, trustee, employee or agent of another corporation, limited liability company, partnership, joint venture, trust or other enterprise, in each case whether or not serving in such capacity at the time any liability or expense is incurred for which indemnification, reimbursement, or advancement can be provided under this Agreement. 
		

		
			(b) For the purpose hereof, references to “fines” shall include any excise tax assessed with respect to any employee benefit plan; references to “serving at the request of the Company” shall include any service as a director, officer, employee or agent of the Company which imposes duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its participants or beneficiaries; and a Person who acted in good faith and in a manner such Person reasonably believed to be in the best interests of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner “not opposed to the best interests of the Company” as referred to in this Agreement.
		

		
			2.Indemnity in Third-Party Proceedings. The Company shall indemnify and hold harmless Indemnitee, to the fullest extent permitted by applicable law, from and against all Liabilities and Expenses suffered or reasonably incurred (and, in the case of retainers, reasonably expected to be incurred) by Indemnitee or on Indemnitee’s behalf in connection with any Proceeding (other than any Proceeding brought by or in the right of the Company to procure a judgment in its favor, which is provided for in Section 3 below), or any claim, issue or matter therein.
		

		
			3.Indemnity in Proceedings by or in the Right of the Company. The Company shall indemnify and hold harmless Indemnitee, to the fullest extent permitted by applicable law, from and against all Liabilities and Expenses suffered or incurred (and, in the case of retainers, reasonably expected to be incurred) by Indemnitee or on Indemnitee’s behalf in connection with any Proceeding brought by or in the right of the Company to procure a judgment in its favor, or any claim, issue or matter therein. No indemnification for Expenses shall be made under this Section 3 in respect of any claim, issue or matter as to which Indemnitee shall have been finally adjudged by a court to be liable to the Company, unless and only to the extent that the Delaware Court of Chancery or any court in which the Proceeding was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnification.
		

		
			4.Indemnification for Expenses of a Party Who is Wholly or Partly Successful. Notwithstanding any other provisions of this Agreement, and without limiting the rights of Indemnitee under any other provision hereof, including any rights to indemnification pursuant to Sections 2 or 3 hereof, to the fullest extent permitted by applicable law, to the extent that Indemnitee is successful, on the merits or otherwise, in any Proceeding or in defense of any claim, issue or matter therein, in whole or in part, the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred (and, in the case of retainers, reasonably expected to be incurred) by Indemnitee or on Indemnitee’s behalf in connection with each successfully resolved Proceeding, claim, issue or matter. For purposes of this Section 4 and without limitation, the termination of any Proceeding or claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter.
		

		
			5.Indemnification For Expenses of a Witness. Notwithstanding any other provision of this Agreement, to the fullest extent permitted by applicable law and to the extent that Indemnitee is, by reason of Indemnitee’s Corporate Status, a witness or otherwise a participant, including by a request to respond to discovery requests, receipt of a subpoena or similar demand for documents or testimony, in any Proceeding to which Indemnitee is not a party and is not threatened to be made a party, Indemnitee shall be indemnified against all Expenses suffered or incurred (or, in the case of retainers, reasonably expected to be incurred) by Indemnitee or on Indemnitee’s behalf in connection therewith.
		

		
			6.Additional Indemnification. Notwithstanding any limitation in Sections 2,  3 or 4 hereof, the Company shall indemnify Indemnitee to the fullest extent permitted by applicable law if Indemnitee is a party to 

		 

 

or threatened to be made a party to any Proceeding (including a Proceeding by or in the right of the Company to procure a judgment in its favor) against all Liabilities and Expenses suffered or reasonably incurred (and, in the case of retainers, reasonably expected to be incurred) by Indemnitee in connection with such Proceeding, including but not limited to:
		

		
			(a) the fullest extent permitted by the provision of the DGCL that authorizes or contemplates additional indemnification by agreement, or the corresponding provision of any amendment to or replacement of the DGCL; and
		

		
			(b) the fullest extent authorized or permitted by any amendments to or replacements of the DGCL adopted after the date of this Agreement that increase the extent to which a corporation may indemnify its officers and directors.
		

		
			7.Exclusions. Notwithstanding any provision in this Agreement, the Company shall not be obligated under this Agreement to indemnify or hold harmless Indemnitee, or, in the case of (a) and (d), to advance Expenses to Indemnitee:
		

		
			(a) for which payment has actually been made to or on behalf of Indemnitee under any insurance policy obtained by the Company except with respect to any excess beyond the amount paid under such insurance policy;
		

		
			(b) for an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within the meaning of Section 16(b) of the Exchange Act or similar provisions of state statutory law or common law;
		

		
			(c) for any reimbursement of the Company by Indemnitee of any bonus or other incentive-based or equity-based compensation or of any profits realized by Indemnitee from the sale of securities of the Corporation, as required in each case under the Exchange Act (including any such reimbursements that arise from an accounting restatement of the Corporation pursuant to Section 304 of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”), or the payment to the Corporation of profits arising from the purchase and sale by Indemnitee of securities in violation of Section 306 of the Sarbanes-Oxley Act), if Indemnitee is held liable therefor (including pursuant to any settlement arrangements) or in respect of claw-back provisions promulgated under the rules and regulations of the Securities and Exchange Commission pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act;
		

		
			(d) except as provided in Section 12(d) of this Agreement, in connection with any Proceeding (or any part of any Proceeding) initiated by Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by Indemnitee, against the Company or its directors, officers, employees or other indemnitees, unless (i) the Board authorized the Proceeding (or any part of any Proceeding) prior to its initiation, (ii) the Company provides the indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law or (iii) such Proceeding is being brought by Indemnitee to assert, interpret or enforce Indemnitee’s rights under this Agreement (for the avoidance of doubt, Indemnitee shall not be deemed, for purposes of this subsection, to have initiated or brought any claim by reason of (A) having asserted any affirmative defenses in connection with a claim not initiated by Indemnitee or (B) having made any counterclaim (whether permissive or mandatory) in connection with any claim not initiated by Indemnitee); or
		

		
			(e) if a final decision by a court having jurisdiction in the matter that is not subject to appeal shall determine that such indemnification is not lawful.
		

		
			8.Advancement. In accordance with the pre-existing requirements of the Bylaws, and notwithstanding any provision of this Agreement to the contrary, the Company shall advance, to the extent not prohibited by applicable law, the Expenses and Liabilities reasonably incurred by Indemnitee in connection with any Proceeding, and such advancement shall be made within ten (10) days after the receipt by the Company of a statement or statements requesting such advances from time to time, whether prior to or after final disposition of any Proceeding. Advances shall be unsecured and interest free. Advances shall be made without regard to Indemnitee’s ability to repay the Expenses and without regard to 

		 

 

Indemnitee’s ultimate entitlement to indemnification under the other provisions of this Agreement. Advances shall include any and all Expenses reasonably incurred pursuing an action to enforce this right of advancement, including Expenses incurred preparing and forwarding statements to the Company to support the advances claimed. Indemnitee shall qualify for advances upon the execution and delivery to the Company of this Agreement, which shall constitute an undertaking providing that Indemnitee undertakes to repay the amounts advanced to the extent that it is ultimately determined by final judicial decision from which there is no further right to appeal that the Indemnitee is not entitled to be indemnified by the Company. Nothing in this Section 8 shall limit Indemnitee’s right to advancement pursuant to Section 12(d) of this Agreement. This Section 8 shall not apply to any claim made by Indemnitee for which indemnity is excluded pursuant to Sections 7(a) or (d) hereof.
		

		
			9.Procedure for Notification and Defense of Claim.
		

		
			(a) Indemnitee shall promptly notify the Company in writing of any Proceeding with respect to which Indemnitee intends to seek indemnification or advancement hereunder following the receipt by Indemnitee of written notice thereof (the date of such notification, the “Submission Date”). The written notification to the Company shall include a description of the nature of the Proceeding and the facts underlying the Proceeding. To obtain indemnification under this Agreement, Indemnitee shall submit to the Company a written request, including therein or therewith such documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what extent Indemnitee is entitled to indemnification following the final disposition of such Proceeding, including any appeal therein. Any delay or failure by Indemnitee to notify the Company hereunder will not relieve the Company from any liability which it may have to Indemnitee hereunder or otherwise than under this Agreement, and any delay or failure in so notifying the Company shall not constitute a waiver by Indemnitee of any rights under this Agreement. The Secretary of the Company shall, promptly upon receipt of such a request for indemnification, advise the Board in writing that Indemnitee has requested indemnification.
		

		
			(b) In the event Indemnitee is entitled to indemnification and/or advancement with respect to any Proceeding, Indemnitee may, at Indemnitee’s option, (i) retain counsel (including local counsel) selected by Indemnitee and approved by the Company to defend Indemnitee in such Proceeding, at the sole expense of the Company (which approval shall not be unreasonably withheld, conditioned or delayed), or (ii) have the Company assume the defense of Indemnitee in such Proceeding, in which case the Company shall assume the defense of such Proceeding with counsel selected by the Company and approved by Indemnitee (which approval shall not be unreasonably withheld, conditioned or delayed) within ten (10) days of the Company’s receipt of written notice of Indemnitee’s election to cause the Company to do so. If the Company is required to assume the defense of any such Proceeding, it shall engage legal counsel for such defense, and the Company shall be solely responsible for all fees and expenses of such legal counsel and otherwise of such defense. Such legal counsel may represent both Indemnitee and the Company (and any other party or parties entitled to be indemnified by the Company with respect to such matter) unless, in the reasonable opinion of legal counsel to Indemnitee, there is a conflict of interest between Indemnitee and the Company (or any other such party or parties) or there are legal defenses available to Indemnitee that are not available to the Company (or any such other party or parties). Notwithstanding either party’s assumption of responsibility for defense of a Proceeding, each party shall have the right to engage separate counsel at its own expense. If the Company has responsibility for defense of a Proceeding, the Company shall provide the Indemnitee and its counsel with all copies of pleadings and material correspondence relating to the Proceeding. Indemnitee and the Company shall reasonably cooperate in the defense of any Proceeding with respect to which indemnification is sought hereunder, regardless of whether the Company or Indemnitee assumes the defense thereof. Indemnitee may not settle or compromise any Proceeding without the prior written consent of the Company, which consent shall not be unreasonably withheld, conditioned or delayed. The Company may not settle or compromise any Proceeding without the prior written consent of Indemnitee.
		

		
			10.Procedure Upon Application for Indemnification.
		

		
			

		 

 

		

		
			(a) Upon written request by Indemnitee for indemnification pursuant to Section 9(a) hereof, if any determination by the Company is required by applicable law with respect to Indemnitee’s entitlement thereto, such determination shall be made (i) if Indemnitee shall request such determination be made by Independent Counsel, by Independent Counsel, and (ii) in all other circumstances, (A) by a majority vote of the Disinterested Directors, even though less than a quorum of the Board, (B) by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors, even though less than a quorum of the Board, (C) if there are no such Disinterested Directors or, if such Disinterested Directors so direct, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee, or (D) if so directed by the Board, by the stockholders of the Company holding a majority of the securities of the Company entitled to vote; and, if it is so determined that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made within ten (10) days after such determination. Indemnitee shall cooperate with the person, persons or entity making such determination with respect to Indemnitee’s entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such determination. Any Expenses incurred by Indemnitee in so cooperating with the person, persons or entity making such determination shall, to the fullest extent permitted by law, be borne by the Company (irrespective of the determination as to Indemnitee’s entitlement to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom. The Company will not deny any written request for indemnification hereunder made in good faith by Indemnitee unless a determination as to Indemnitee’s entitlement to such indemnification described in this Section 10(a) has been made. The Company agrees to pay the reasonable fees and expenses of the Independent Counsel referred to above and to fully indemnify such counsel against any and all Liabilities and Expenses arising out of or relating to this Agreement or its engagement pursuant hereto.
		

		
			(b) In the event the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 10(a) hereof, (i) the Independent Counsel shall be selected by the Company within ten (10) days of the Submission Date (the cost of such Independent Counsel to be paid by the Company), (ii) the Company shall give written notice to Indemnitee advising it of the identity of the Independent Counsel so selected and (iii) Indemnitee may, within ten (10) days after such written notice of selection shall have been given, deliver to the Company Indemnitee’s written objection to such selection. Such objection by Indemnitee may be asserted only on the ground that the Independent Counsel selected does not meet the requirements of “Independent Counsel” as defined in this Agreement. If such written objection is made and substantiated, the Independent Counsel selected shall not serve as Independent Counsel unless and until Indemnitee withdraws the objection or a court has determined that such objection is without merit. Absent a timely objection, the person so selected shall act as Independent Counsel. If no Independent Counsel shall have been selected and not objected to before the later of (A) thirty (30) days after the Submission Date and (B) ten (10) days after the final disposition of the Proceeding, including any appeal therein, each of the Company and Indemnitee shall select a law firm or member of a law firm meeting the qualifications to serve as Independent Counsel, and such law firms or members of law firms shall select the Independent Counsel.
		

		
			Upon the due commencement of any judicial proceeding or arbitration pursuant to Section 12(a) of this Agreement, Independent Counsel shall be discharged and relieved of any further responsibility in such capacity (subject to the applicable standards of professional conduct then prevailing).
		

		
			11.Presumptions and Effect of Certain Proceedings.
		

		
			(a) In making a determination with respect to entitlement to indemnification hereunder, the person, persons or entity making such determination shall, to the fullest extent not prohibited by applicable law, presume that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification in accordance with Section 9(a) of this Agreement, and the Company shall, to the fullest extent not prohibited by applicable law, have the burden of proof to overcome that presumption in connection with the making by any person, persons or entity of any determination contrary to that presumption. Neither the failure of the Company (including by its directors 

		 

 

or Independent Counsel) to have made a determination prior to the commencement of any action pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual determination by the Company (including by its directors or Independent Counsel) that Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has not met the applicable standard of conduct.
		

		
			(b) Subject to Section 12(d) hereof, if the person, persons or entity empowered or selected under Section 10 of this Agreement to determine whether Indemnitee is entitled to indemnification shall not have made a determination within sixty (60) days after receipt by the Company of the request therefore, the requisite determination of entitlement to indemnification shall, to the fullest extent not prohibited by applicable law, be deemed to have been made and Indemnitee shall be entitled to such indemnification, absent a prohibition of such indemnification under applicable law; provided, however, that such 60-day period may be extended for a reasonable time, not to exceed an additional thirty (30) days, if (i) the determination is to be made by Independent Counsel and Indemnitee objects to the Company’s selection of Independent Counsel and (ii) the Independent Counsel ultimately selected requires such additional time for the obtaining or evaluating of documentation or information relating thereto; provided further, however, that such 60-day period may also be extended for a reasonable time, not to exceed an additional sixty (60) days, if the determination of entitlement to indemnification is to be made by the stockholders of the Company.
		

		
			(c) The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) adversely affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which Indemnitee reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that Indemnitee’s conduct was unlawful.
		

		
			(d) Reliance as Safe Harbor. For purposes of any determination of good faith, Indemnitee shall be deemed to have acted in good faith if Indemnitee’s action is based on the records or books of account of the Enterprise, including financial statements, or on information supplied to Indemnitee by the officers of the Enterprise in the course of their duties, or on the advice of legal counsel for the Enterprise or on information or records given or reports made to the Enterprise by an independent certified public accountant or by an appraiser or other expert selected with the reasonable care by the Enterprise. The provisions of this Section 11(d) shall not be deemed to be exclusive or to limit in any way the other circumstances in which Indemnitee may be deemed to have met the applicable standard of conduct set forth in this Agreement.
		

		
			(e) Actions of Others. The knowledge or actions, or failure to act, of any director, officer, agent or employee of the Enterprise shall not be imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement.
		

		
			12.Remedies of Indemnitee.
		

		
			(a) Subject to Section 12(d) hereof, in the event that (i) a determination is made pursuant to Section 10 of this Agreement that Indemnitee is not entitled to indemnification under this Agreement, (ii) advancement is not timely made pursuant to Section 8 of this Agreement, (iii) no determination of entitlement to indemnification shall have been timely made pursuant to Section 10(a) of this Agreement within sixty (60) days after receipt by the Company of the request for indemnification, (iv) payment of indemnification is not made pursuant to Sections 4 or 5 or the third to the last sentence of Section 10(a) of this Agreement within ten (10) days after receipt by the Company of a written request therefor, (v) payment of indemnification pursuant to Sections 2,  3 or 6 of this Agreement is not made within ten (10) days after a determination has been made that Indemnitee is entitled to indemnification, or (vi) in the event that the Company or any other Person takes or threatens to take any action to declare this Agreement void or unenforceable, or institutes any litigation or other action or proceeding designed to deny, or to recover from, Indemnitee the benefits provided or intended to be provided to Indemnitee 

		 

 

hereunder, Indemnitee shall be entitled to an adjudication by a court of Indemnitee’s entitlement to such indemnification or advancement. Alternatively, Indemnitee, at Indemnitee’s option, may seek an award in arbitration to be conducted by a single arbitrator pursuant to the Commercial Arbitration Rules of the American Arbitration Association. The Company shall not oppose Indemnitee’s right to seek any such adjudication or award in arbitration.
		

		
			(b) In the event that a determination shall have been made pursuant to Section 10(a) of this Agreement that Indemnitee is not entitled to indemnification, any judicial proceeding or arbitration commenced pursuant to this Section 12 shall be conducted in all respects as a de novo trial, or arbitration, on the merits and Indemnitee shall not be prejudiced by reason of that adverse determination. In any judicial proceeding or arbitration commenced pursuant to this Section 12 the Company shall have the burden of proving Indemnitee is not entitled to indemnification or advancement, as the case may be.
		

		
			(c) If a determination shall have been made pursuant to Section 10(a) of this Agreement that Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section 12, absent a prohibition of such indemnification under applicable law.
		

		
			(d) The Company shall, to the fullest extent not prohibited by applicable law, be precluded from asserting in any judicial proceeding or arbitration commenced pursuant to this Section 12 that the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court or before any such arbitrator that the Company is bound by all the provisions of this Agreement. It is the intent of the Company that Indemnitee not be required to incur Expenses associated with the interpretation, enforcement or defense of Indemnitee’s rights under this Agreement by litigation or otherwise because the cost and expense thereof would substantially detract from the benefits intended to be extended to Indemnitee hereunder. The Company shall indemnify Indemnitee against any and all Expenses and, if requested by Indemnitee, shall (within ten (10) days after receipt by the Company of a written request therefore) advance, to the extent not prohibited by applicable law, such Expenses to Indemnitee, which are incurred by Indemnitee in connection with any action brought by Indemnitee for indemnification or advancement from the Company under this Agreement or the Bylaws, or under any directors’ and officers’ liability insurance policies maintained by the Company, regardless of whether Indemnitee ultimately is determined to be entitled to such indemnification, advancement or insurance recovery, as the case may be.
		

		
			(e) Notwithstanding anything in this Agreement to the contrary, no determination as to entitlement to indemnification under this Agreement shall be required to be made prior to the final disposition of the Proceeding, including any appeal therein; provided that, in absence of any such determination with respect to such Proceeding, the Company shall advance Expenses with respect to such Proceeding.
		

		
			13.Non-Exclusivity; Survival of Rights; Insurance; Subrogation.
		

		
			(a) The rights of indemnification and to receive advancement as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled under applicable law, the Certificate of Incorporation, the Bylaws, any agreement, a vote of stockholders or a resolution of directors, or otherwise. No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee under this Agreement in respect of any action taken or omitted by such Indemnitee in Indemnitee’s Corporate Status prior to such amendment, alteration or repeal. The Company shall not adopt any amendment or alteration to, or repeal of, the Certificate of Incorporation or the Bylaws, the effect of which would be to deny, diminish or encumber the Indemnitee’s rights to indemnification pursuant to this Agreement, the Certificate of Incorporation, the Bylaws or applicable law relative to such rights prior to such amendment, alteration or repeal. To the extent that a change in Delaware law, whether by statute or judicial decision, permits greater indemnification or advancement than would be afforded currently under the Bylaws or this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the greater benefits so afforded by such change. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. 

		 

 

The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy.
		

		
			(b) The Company hereby acknowledges that Indemnitee may have certain rights to indemnification, advancement and insurance provided by one or more Persons with whom or which Indemnitee may be associated. The Company hereby acknowledges and agrees that (i) the Company shall be the indemnitor of first resort with respect to any Proceeding, Expense, Liability or matter that is the subject of the Indemnity Obligations, (ii) the Company shall be primarily liable for all Indemnity Obligations and any indemnification afforded to Indemnitee in respect of any Proceeding, Expense, Liability or matter that is the subject of Indemnity Obligations, whether created by applicable law, organizational or constituent documents, contract (including this Agreement) or otherwise, (iii) any obligation of any other Persons with whom or which Indemnitee may be associated to indemnify Indemnitee or advance Expenses or Liabilities to Indemnitee in respect of any Proceeding shall be secondary to the obligations of the Company hereunder, (iv) the Company shall be required to indemnify Indemnitee and advance Expenses or Liabilities to Indemnitee hereunder to the fullest extent provided herein without regard to any rights Indemnitee may have against any other Person with whom or which Indemnitee may be associated or insurer of any such Person and (v) the Company irrevocably waives, relinquishes and releases any other Person with whom or which Indemnitee may be associated from any claim of contribution, subrogation or any other recovery of any kind in respect of amounts paid by the Company hereunder. In the event any other Person with whom or which Indemnitee may be associated or their insurers advances or extinguishes any liability or loss which is the subject of any Indemnity Obligation owed by the Company or payable under any Company insurance policy, the payor shall have a right of subrogation against the Company or its insurer or insurers for all amounts so paid which would otherwise be payable by the Company or its insurer or insurers under this Agreement. In no event will payment of an Indemnity Obligation by any other Person with whom or which Indemnitee may be associated or their insurers affect the obligations of the Company hereunder or shift primary liability for any Indemnity Obligation to any other Person with whom or which Indemnitee may be associated. Any indemnification, insurance or advancement provided by any other Person with whom or which Indemnitee may be associated with respect to any liability arising as a result of Indemnitee’s Corporate Status or capacity as an officer or director of any Person is specifically in excess over any Indemnity Obligation of the Company or valid and any collectible insurance (including but not limited to any malpractice insurance or professional errors and omissions insurance) provided by the Company under this Agreement.
		

		
			(c) The Company shall maintain an insurance policy or policies providing liability insurance providing reasonable and customary coverage as compared with similarly situated companies (as determined by the Board in its reasonable discretion) for directors, officers, employees, trustees, or agents of any Enterprise, and Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for any such director, officer, employee, trustee or agent under such policy or policies and such policies shall provide for and recognize that the insurance policies are primary to any rights to indemnification, advancement or insurance proceeds to which Indemnitee may be entitled from one or more Persons with whom or which Indemnitee may be associated to the same extent as the Company’s indemnification and advancement obligations set forth in this Agreement. If, at the time of the receipt of a notice of a claim pursuant to the terms hereof, the Company has director and officer liability insurance in effect, the Company shall give prompt notice of the commencement of such Proceeding to the insurers in accordance with the procedures set forth in the respective policies. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such Proceeding in accordance with the terms of such policies.
		

		
			(d) In the event of any payment under this Agreement, the Company shall be subrogated to the rights of recovery of Indemnitee, including rights of indemnification provided to Indemnitee from any other person or entity with whom Indemnitee may be associated; provided, however, that the Company shall not be subrogated to the extent of any such payment of all rights of recovery of Indemnitee with respect to any Person with whom or which Indemnitee may be associated.
		

		
			

		 

 

		

		
			(e) The indemnification and contribution provided for in this Agreement will remain in full force and effect regardless of any investigation made by or on behalf of Indemnitee.
		

		
			14.Duration of Agreement; Not Employment Contract. This Agreement shall continue until and terminate upon the latest of: (i) ten (10) years after the date that Indemnitee shall have ceased to serve as director, officer, employee or agent of the Company or any other Enterprise, (ii) one (1) year after the date of final termination of any Proceeding, including any appeal, then pending in respect of which Indemnitee is granted rights of indemnification or advancement hereunder and of any proceeding, including any appeal, commenced by Indemnitee pursuant to Section 12 of this Agreement relating thereto or (iii) the expiration of all statutes of limitation applicable to possible Proceedings to which Indemnitee may be subject arising out of Indemnitee’s Corporate Status. The indemnification provided under this Agreement shall continue as to the Indemnitee even though he or she may have ceased to be a director or officer of the Company or of any of the Company’s direct or indirect subsidiaries or to have Corporate Status. This Agreement shall be binding upon the Company and its successors and assigns and shall inure to the benefit of Indemnitee and Indemnitee’s heirs, executors and administrators. The Company shall require and cause any successor, and any direct or indirect parent of any successor, whether direct or indirect by purchase, merger, consolidation or otherwise, to all, substantially all or a substantial part, of the business and/or assets of the Company, by written agreement in form and substance satisfactory to Indemnitee, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place. This Agreement shall not be deemed an employment contract between the Company (or any of its subsidiaries or any other Enterprise) and Indemnitee. Indemnitee specifically acknowledges that Indemnitee’s employment with the Company (or any of its subsidiaries or any other Enterprise), if any, is at will, and Indemnitee may be discharged at any time for any reason, with or without cause, except as may be otherwise provided in any written employment contract between Indemnitee and the Company (or any of its subsidiaries or any other Enterprise), other applicable formal severance policies duly adopted by the Board, or, with respect to service as a director of the Company, by the Certificate of Incorporation, the Bylaws or the DGCL.
		

		
			15.Severability. If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a) the validity, legality and enforceability of the remaining provisions of this Agreement (including, without limitation, each portion of any Section of this Agreement containing any such provision held to be invalid, illegal or unenforceable that is not itself invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent permitted by applicable law; (b) such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law and to give the maximum effect to the intent of the parties hereto; and (c) to the fullest extent possible, the provisions of this Agreement (including, without limitation, each portion of any Section of this Agreement containing any such provision held to be invalid, illegal or unenforceable that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested thereby.
		

		
			16.Enforcement.
		

		
			(a) The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in order to induce Indemnitee to serve as a director, officer, employee or agent of the Company, and the Company acknowledges that Indemnitee is relying upon this Agreement in serving as a director, officer, employee or agent of the Company.
		

		
			(b) This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof; provided, however, that this Agreement is a supplement to and in furtherance of the Certificate of Incorporation, the Bylaws and applicable law, and shall not be deemed a substitute therefore, nor diminish or abrogate any rights of Indemnitee thereunder.
		

		
			17.Modification and Waiver. No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by the parties thereto. No waiver of any of the provisions of this 

		 

 

Agreement shall be deemed to be or shall constitute a waiver of any other provision of this Agreement nor shall any waiver constitute a continuing waiver.
		

		
			18.Notices. All notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed to have been duly given if (a) delivered by hand and receipted for by the party to whom said notice or other communication shall have been directed, (b) mailed by certified or registered mail with postage prepaid, on the third business day after the date on which it is so mailed, (c) mailed by reputable overnight courier and receipted for by the party to whom said notice or other communication shall have been directed or (d) sent by facsimile transmission, with receipt of oral confirmation that such transmission has been received:
		

		
			(i) If to Indemnitee, at the address indicated on the signature page of this Agreement, or such other address as Indemnitee shall provide to the Company.
		

		
			(ii) If to the Company to
		

		
			Solaris Oilfield Infrastructure, Inc.
		

		
			9811 Katy Freeway, Suite 900
		

		
			Houston, Texas 77024
		

		
			Attention: Board of Directors
		

		
			or to any other address as may have been furnished to Indemnitee by the Company.
		

		
			19.Contribution. To the fullest extent permissible under applicable law, if the indemnification provided for in this Agreement is unavailable to Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by Indemnitee, whether for Liabilities or for Expenses, in connection with any Proceeding, in such proportion as is deemed fair and reasonable in light of all of the circumstances of such Proceeding in order to reflect (a) the relative benefits received by the Company and Indemnitee as a result of the event(s) and transaction(s) giving cause to such Proceeding; and (b) the relative fault of the Company (and its directors, officers, employees and agents) and Indemnitee in connection with such event(s) and transaction(s).
		

		
			20.Applicable Law. This Agreement and the legal relations among the parties shall be governed by, and construed and enforced in accordance with, the laws of the State of Delaware, without regard to its conflict of laws rules.
		

		
			21.Counterparts. This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same Agreement. Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of this Agreement.
		

		
			 
		

		
			[Signature Page Follows]
		

		
			
		

		
			

		 

 

		

		
			IN WITNESS WHEREOF, the parties have caused this Agreement to be signed as of the day and year first above written.
		

			
					
						 

					
					
						 

					
					
						 

				
	
					
						 

				
	
					
						 

				
	
					
						SOLARIS OILFIELD INFRASTRUCTURE,

				
	
					
						 

				
	
					
						 

				
	
					
						By:

					
					
						/s/ Kyle S. Ramachandran

				
	
					
						Name:

					
					
						Kyle S. Ramachandran

				
	
					
						Title:

					
					
						Chief Financial Officer

				
	
					
						 

				
	
					
						 

				
	
					
						 

				
	
					
						 

				
	
					
						INDEMNITEE

				
	
					
						 

				
	
					
						By:

					
					
						/s/ Christopher M. Powell

					
					
						 

				
	
					
						Name:

					
					
						Christopher M. Powell

					
					
						 

				
	
					
						Title:

					
					
						General Counsel

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00276-of-00352.parquet"}]]